Opening Ceremony

Time: 09:00-09:30, June 22, 2010 (Turesday)  Place: Conference Hall, 2F

Moderator

Keynote Forum

Time: 09:35-11:15, June 22, 2010 (Tuesday)  Place: Conference Hall, 2F

Dr. Jin Jen, Director, Microarray Shared Resources, Advanced Genomics Technology Center; Senior Associate Consultant, Department of Pulmonary and Critical Care Medicine, Mayo Clinic, USA

09:35-10:00

Title: Whence Epithelial Ovarian Carcinoma
Dr. Jeff Boyd, Senior Vice President, Chief Scientific Officer, Fox Chase Cancer Center, USA

10:00-10:25

Title: Epigenomic Changes In Gastrointestinal Cancers Related To Disease Progression and Outcome  
Dr. Dave S. B. Hoon, Director, Department of Molecular Oncology, John Wayne Cancer Institute, USA

10:25-10:50

Title: Targeted Therapy and Molecular Imaging
Dr. Hartmuth C. Kolb, Vice President, Siemens Medical Solutions, USA, Molecular Imaging, USA

10:50-11:15

Title: Array-based Diagnostics: A Paradigm Shift in the Diagnosis of Cancers
Dr. Mansoor Mohammed, President and CEO, ComniMatrix Diagnostics, USA

Track 1-1: Breast Cancer, Ovarian and Cervical Cancer （Part I） Click here for Part Ⅱ

Time: 13:30-16:40, June 22, 2010 (Tuesday),   Place: Conference Hall A, 2F

Session Chair

Dr. Vundavalli V. Murty, Associate Professor ,Columbia University Medical Center, USA

Session Co-Chair

Dr. Kenneth R. Shroyer, Professor and Chair, Department of Pathology, Stony Brook University Medical Center, USA

13:30-13:55

Title: Molecular Genetics of Cervical Cancer
Dr. Vundavalli V. Murty, Associate Professor ,Columbia University Medical Center, USA

13:55-14:20

Title: Molecular Markers of HPV and Cervical Cancer: Biomarker Discovery and Validation
Dr. Kenneth R. Shroyer, Professor and Chair, Department of Pathology, Stony Brook University Medical Center, USA

14:20-14:45

Title: Discovery of Biomarkers in Epithelial Ovarian Cancer by Proteomic Technology
Dr. Song-Nan Chow, Professor & President of TFDBT, Department of Obstetrics & Gynecology, National Taiwan University Hospital, Taiwan

14:45-15:10

Title: Estrogen Receptor Activation Confer Nicotine and Estrogen-induced 9-nAchR Expression in Human Breast Cancer Cells
Dr. Yuan-Soon Ho, Professor/Chairman, Translational Cancer Research Center, Graduate Institute of Biomedical Technology, Taipei Medical University, Taiwan

15:10-15:25

Coffee Break

15:25-15:50

Title: Mammary Gland Morphological and Gene Expression Changes Underlying Pregnancy Protection of Breast Cancer Tumorigenesis
Dr. Feng-Qi Zhao, Associate Professor, Department of Animal Science, The University of Vermont, USA

15:50-16:15

Title: Molecular Imaging in Gynecologic Cancers
Dr. Chyong-Huey Lai, Professor, Chang Gung Memorial Hospital, Chang Gung University, Taiwan

16:15-16: 40

Title: The Information Needs and Perceived Social Support and Coping Mechanisms of Chinese-australian Women with Breast Cancer
Dr. Cannas Kwok, Cancer Institute NSW Research Fellow, Sydney Nursing School, The University of Sydney, Australia

Track 1-2: Prostate Cancer

Time: 13:30-15:10, June 22, 2010 (Tuesday)    Place: Conference Hall E, 2F

Session Chair

Dr. Peng Lee, Associate Professor of Pathology and Urology, New York University School of Medicine, Director, Molecular Pathology, New York Harbor Healthcare System, USA

13:30-13:50

Title: Androgen Receptor and its Coactivators in Prostate Cancer: Novel Mechanisms for Androgen-independent Disease
Dr. Peng Lee, Associate Professor of Pathology and Urology, New York University School of Medicine, Director, Molecular Pathology, New York Harbor Healthcare System, USA

13:50-14:10

Title: Actin Binding Proteins in Prostate Cancer Development
Dr. Stephen J. Assinder, University of Sydney, Australia

14:10-14:30

Title: Miniaturized 3D Cell Culture Models of Prostate Cancer for Drug Discovery & Validation
Dr. Matthias Nees, Senior Scientist, VTT Medical Biotechnology, Finland

14:30-14:50

Title: A Multidisciplinary Approach to Prostate Cancer Research
Dr. Stephen Brassell, Walter Reed Army Medical Center, USA

14:50-15:10

Title: Activation of G-protein Coupled Receptor 30 (GPR30) Inhibits the Growth of Prostate Cancer              Cells through Sustained Activation of Erk1/2, C-jun/c-fos-dependent Upregulation of p21, and                           Induction of G(2) Cell-cycle Arrest
Dr. Kin-Mang Lau, Assistant Professor, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, China

Track 1-3: Colorectal and Colon Cancers

Time: 13:30-16:45, June 23, 2010 (Wednesday)    Place: Conference Hall A, 2F

Session Chair

Dr. Ned Abraham, Professor of Surgery Coffs Harbour Campus, Faculty of Medicine, University of New South Wales Colorectal & General Surgeon & Endoscopist, Coffs Colorectal & Capsule Endoscopy Centre, Australia

Session Co-Chair

Dr. Arthur Sun Myint, Director, Minimally Invasive Radiotherapy Course at Clatterbridge, UK

13:30-13:50

Title: Fast Track Colorectal Cancer Resection, Laparoscopic Resection or Both?
Dr. Ned Abraham, Associate Professor of Surgery, Faculty of Medicine, University of New South Wales , Australia

13:50-14:10

Title: Combined Modality Treatment for Early Rectal Cancer
Dr. Arthur Sun Myint,Director, Minimally Invasive Radiotherapy Course at Clatterbridge, UK

14:10-14:30

Title: Chemoradiotherapy for Rectal Cancer
Dr. Soe Aung, Professor/Consultant Medical Oncologist, Oncology Department, Yangon General Hospital, Unit Leader (Clinical Research Unit), Myanmar

14:30-14:50

Title: An Overview of Colon Cancer and its Prevention and Treatment
Dr. Somashekar Shyale, Professor and HOD, Department of Pharmaceutics, V.l. College of Pharmacy, India

14:50-15:10

Title: Screening for Colorectal Cancers in the Average Population: When and How can We Do It
Dr. Esther Una Cidon, Assistant Professor, Clinical University Hospital and School of Medicine, Spain

15:10-15:25

Coffee Break

15:25-15:45

Title: Personalized Treatment of Colorectal Cancer – Are We There yet?
Dr. Yew Oo Tan, Medical Oncology Centre, Singapore

15:45-16:05

Title: Monitoring Rectal Tumour Post Chemo Radiation: Magnetic Resonance Imaging - What is the Picture?
Dr. Apam Chiphang, Lead CT/MR Consultant GI Radiologist, Southport and Ormskirk NHS Trust, UK

16:05-16:25

Title: Primary Site Resection is Superior to Palliative Surgical Treatment for Noncurable Metastatic Colorectal Cancer Treated With Adjuvant Chemotherapy: A Retrospective, Observational Study Of Perioperative Outcome And Long-term Survival
Dr.Yusuke Tanoue, Department of Oncological and Vascular Surgery, University of Tokyo, Japan

16:25-16:45

Title: Presence of Activating KRAS Mutations Correlates Significantly with Expression of Tumour Suppressor Genes DCN and TPM1 in Colorectal Cancer
Dr. Simona Jurković Mlakar, Young Researcher / Assistant, University of Ljubljana, Clinical Institute of Clinical Chemistry and Biochemistry, Slovenia

Track 1-4: Nuclear Oncology-Diagnosis and Therapy

Time: 13:30-17:05, June 22, 2010 (Tuesday)    Place: Conference Hall B, 2F

Session Chair

Dr. James J. Zhang, Global Head of Clinical Development, Siemens Molecular Imaging Inc., USA

Session Co-Chair

Dr. Amr Amin, Associate Professor, Biology Department, UAE University, UAE

13:30-13:55

Title: New PET Biomarkers in Nuclear Oncology
Dr. James J. Zhang, Global Head of Clinical Development, Siemens Molecular Imaging Inc., USA

13:55-14:20

Title: MRI-based Texture Analysis as a Potential Noninvasive Approach to Assess Potential Protection Against Induced-Liver Fibrosis
Dr. Amr Amin, Associate Professor, Biology Department, UAE University, UAE

14:20-14:45

Title: Usefulness of Methione-PET Fusion 3.0T-MRI in the Early Diagnosis of Cushing's Disease and in Evaluating Viable Cells after Radiation and Chemotherapy
Dr. Hidetoshi Ikeda, Head of Research Institute for Pituitary Disease, Southern Tohoku General Hospital, Japan

14:45-15:10

Title: Markedly Reduced Glucose Uptake at Mesothelioma which Appears at Dark Area as Characteristic Finding in PET Scan, & Non-Invasive, Safe Removal of Asbestos by Several Different Methods
Dr. Yoshiaki Omura, Adjunct Professor, Family & Community Medicine, New York Medical College, USA

15:10-15:25

Coffee Break

15:25-15:50

Title: PET Scans, Are They always Helpful?
Dr. Philip Shie, Department of Diagnostic Imaging, Fontana Medical Center, USA

15:50-16:15

Title: Tracer induced Therapy in Cancer Treatment
Dr. M. G. Krukemeyer, Department of Radio-Oncology, Paracelsus-Hospital, Germany

16:15-16:40

Title: The Combination of the 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol Positoron Emission Tomography is New Diagnotic Tool in the Endometrial Cancer
Dr. Yoshio Yoshida, Associate Professor, University of Fukui, Japan

16:40-17:05

Title: Lung Radiofrequency Ablatio (RFA): Indications and Latest Developments
Dr. Karin Steinke, Associate Professor, Royal Brisbane and Women’s Hospital, Australia

Track 1-5: Breast Cancer, Ovarian and Cervical Cancer (Part II)   Click here for Part I

Time: 8:30-10:10, June 23, 2010 (Wednesday)    Place:  Conference Hall A, 2F

Session Chair

Dr. Sherry X. Yang, Chief, National Clinical Target Laboratory, Division of Cancer Treatment and Diagnosis, National Cancer Institute, USA

8:30-8:55

Title: Biomarkers Predict Paclitaxel Chemotherapy Outcome in Patients with Breast Cancer
Dr. Sherry X. Yang, Chief, National Clinical Target Laboratory, Division of Cancer Treatment and Diagnosis, National Cancer Institute, USA

8:55-9:20

Title: Local Control of Invasive Breast Cancer Utilizing a Retrograde Subclavian Artery Resivoir-directed Regional Chemoinfusion with Vascular Redistribution Technique  
Dr. Wael E. A. Saad, Associate Professor of Radiology, University of Virginia Health System, University of Virginia, USA

9:20-9:45

Title: Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients, a Randomized Controlled Trial
Dr. Jill Hervik, Physiotherapist, Pain Clinic, Vestfold Hospital, Norway

9:45-10:10

Title: Laparoscopic Approach Versus Laparotomy for Endometrial Cancer: A Feasible Option
Dr. Angel Luengo Tabernero, Gynecologist & Obstetrician, Ciudad Real General Hospital, Spain

10:10-10:25

Coffee Break

Track 1-6: Pediatric Oncology

Time: 10:25-12:05, June 23, 2010 (Wednesday)    Place: Conference Hall A, 2F

Session Chair

Dr. Luca Lo Nigro, Center of Pediatric Hematology Oncology, Azienda Policlinico­-University of Catania, Italy

Session Co-Chair

Dr. Sedat Alibek, Radiology Institute, University of Erlangen-Nuremberg, Germany

10:25-10:45

Title: The MLL Rearranged Acute Leukemias in Children: from the Bench to the Bedside
Dr. Luca Lo Nigro, Center of Pediatric Hematology Oncology, Azienda Policlinico­-University of Catania, Italy

10:45-11:05

Title: Retrieval Strategies for Childhood Hodgkin Lymphoma
Dr. Caglar CITAK, Associate Professor of Pediatric Oncology, Mersin University Faculty of Medicine, Turkey

11:05-11:25

Title: Asp299Gly Polymorphism of the TLR4 Gene is Associated with a significant Decrease of BK Virus-Induced Hemorrhagic Cystitis after Hematopoietic Stem Cell Transplantation in Childhood
Dr. Bernd Gruhn, Assistant Medical Director, Department of Pediatrics, University of Jena, Germany

11:25-11:45

Title: Prenatal Origin of Childhood Acute Lymphoblastic Leukemia in Children of all Age Group
Dr. Daniel Steinbach, Lecturer, Department of Pediatrics, University Children's Hospital Ulm, Germany

11:45-12:05

Title: Diffusion Weighted MR Imaging in Pediatric Cancer
Dr. Sedat Alibek, Radiology Institute, University of Erlangen-Nuremberg, Germany

Track 1-7: Practical Chemotherapy and Anticancer Drug-Drug Interactions‎

Time: 13:30-14:10, June 23,2010 (Wednesday)     Place: Conference Hall B, 2F

Session Chair

Dr. Hiroshi Ishiguro, Associate Professor, Kyoto University Hospital, Japan

Session Co-Chair

Dr. Yasuhiro Yoshida, Associate Professor, University of Occupational and Environmental Health, Japan

13:30-13:50

Title: Important Drug Interactions for Clinical Oncologists
Dr. Hiroshi Ishiguro, Associate Professor, Kyoto University Hospital, Japan

13:50-14:10

Title: Analysis of Mechanism of the IL -1 induction by New Proteasome Inhibitor Cucurbitacin D.
Dr. Yasuhiro Yoshida, Associate Professor, University of Occupational and Environmental Health, Japan

Track 1-8: Oesophageal and Gastrointestinal Cancers

Time: 14:10-15:30, June 23, 2010 (Wednesday)    Place: Conference Hall B, 2F

Session Chair

Dr. Domenico D’Ugo,Full Professor of Surgery, Director of General Surgery Unit, Catholic University, "A. Gemelli" General Hospital, Italy

14:10-14:30

Title: Long Term Survival after R0 Resection in Locally Advanced Gastric Cancer
Dr. Domenico D'Ugo, Full Professor of Surgery, Director of General Surgery Unit, Catholic University, "A. Gemelli" General Hospital, Italy

14:30-14:50

Title: Laparoscopic Gastrectomy with D2 Lymph Node Dissection
Dr. Seung Ho Choi, Professor, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, South Korea

14:50:15:10

Title: Overall Survival with Cisplatin and 5-Fluorouracil Neoadjuvant Treatment in Patients with Esophageal Cancer: Single-Center Experience
Dr. Efraim Idelevich, Head of the Gastrointestinal Unit of the Institute of Oncology at the Kaplan Medical Center, Israel

Track 1-9: Clinical Oncology

Time: 15:30- 17:10, June 23, 2010 (Wednesday)     Place: Conference Hall B, 2F

Session Chair

Dr. Yutaka Yonemura, President, NPO-Organization to support the Treatment of Peritoneal Surface Malignancy, Japan

Session Co-Chair

Dr. Padma T. Uppala, Associate Professor, Loma Linda University, School of Public Health, USA

15:30- 15:50

Title: A New Concept Regarding The Mechanism of Peritoneal Carcinomatosis: Trans-lymphatic Metastasis
Dr. Yutaka Yonemura, President, NPO-Organization to support the Treatment of Peritoneal Surface Malignancy, Japan

15:50-16:10

Title: Breast Cancer Clinical Trials Knowledge, Attitudes and Practices among Underserved American and Asian Women
Dr. Padma T. Uppala, Associate Professor, Loma Linda University, School of Public Health, USA

16:10-16:30

Title:Conservative Surgery for Differentiated Thyroid Cancer: When and Why
Dr. Bianca Gibelli,Division of Head and Neck Surgery, European Institute of Oncology, Italy

16:30-16:50

Title: Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Carcinoma
Dr. Simon S. Lo, Associate Professor of Radiation Oncology and Neurosurgery, Arthur G. James Cancer Hospital, Ohio State University College of Medicine, USA

16:50-17:10

Title: Imaging of Thyroid Cancer
Dr. J. Matthew Debnam, Assistant Professor, The University of Texas, Anderson Cancer Center, USA

Track 1-10: Tumor Pathology

Time: 13:30-15:10, June 23, 2010 (Wednesday)     Place: Conference Hall H, 1F

Session Chair

Dr. Huamin Wang, Associate Professor, The University of Texas M. D. Anderson Cancer Center, USA

Session Co-Chair

Dr. Sushanta K. Banerjee, Professor, Cancer Research Unit, VA Medical Center, University of Kansas Medical Center, USA

13:30-13:55

Title: Hematopoietic Progenitor Kinase 1, A Novel Tumor Suppressor in Pancreatic Cancer
Dr. Huamin Wang, Associate Professor, The University of Texas M. D. Anderson Cancer Center, USA

13:55-14:20

Title: Clinicopathological Features of Atypical Teratoid / Rhabdoid Tumor: A Malignant Embryonal Tumor as a New Brain Tumor Entity
Dr. Hidehiro Oka, Assistant Professor, Department of Neurosurgery, Kitasato University School of  
Medicine, Japan

14:20-14:45

Title: Human Arrest Defective 1 Protein Suppresses Cancer Cell Metastasis by Binding PIX Proteins and Inhibiting Cdc42/Rac1 Activity
Dr. Min-Liang Kuo, Professor, Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taiwan

14:45-15:10

Title: CCN5 in Breast Cancer: A Regulator of MicroRNA-10b
Dr. Sushanta K. Banerjee, Professor, Cancer Research Unit, VA Medical Center, University of Kansas Medical Center, USA

15:10-15:25

Coffee Break

Track 1-11: Practical Gynecologic Oncology

Time: 10:50-12:05, June 24, 2010 (Thursday)     Place: Conference Hall A, 2F

Session Chair

Dr. Riley Rees, Professor of Surgery (Plastics), University of Michigan, USA  

Session Co-Chair

Dr. Anne W. M. Lee, Chief of Service, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, China  

10:50-11:15

Title: Successful Local Control of Neoplastic Lesions in the Vulva with Cryosurgery
Dr. Juana Elida Mauro, President of the Argentine Society of Cryosurgery, Chief of the Department of Lower Genital Tract and Colposcopy, Durand Hospital, Argentina

11:15-11:40

Title: Current Practice of Radiation Oncology for Treatment of Cervical Cancer: How can We Improve Treatment Outcome
Dr. Eng-Yen Huang, Associate Professor, Chang-gung Memorial Hospital- Kaohsiung Medical Center, Chang Gung University, Taiwan

11:40-12:05

Title: Robotic Surgery in Gynecologic Oncology: The Future is Now
Dr. Susie Lau, Assistant Professor, McGill University, Segal Cancer Centre, Canada

Track 1-12: Head, Nasopharyngeal, Neck, Thyroid and Brain Cancers

Time: 8:30-10:50, June 24, 2010 (Thursday)     Place: Conference Hall A, 2F

Session Chair

Dr. Riley Rees, Professor of Surgery (Plastics), University of Michigan, USA

Session Co-Chair

Dr. Drazen Raucher, Associate Professor, Department of Biochemistry, University of Mississippi Medical Center, USA

8:30-8:55

Title: Melanoma of the Head and Neck: A Surgeons Disease
Dr. Riley Rees, Professor of Surgery (Plastics), University of Michigan, USA

8:55-9:20

Title: Strategies for Management of Radiation Induced Xerostomia in the Management of Head & Neck Cancers
Dr. Naresh Jha, Professor, Cross Cancer Institute, University of Alberta, Canada

9:20-9:45

Title: Role And Regulation Of Upar In Human Glioma Invasion, Angiogenesis And Tumor Growth
Dr. Jasti S. Rao, Professor, Head, University of Illinois College of Medicine, USA

9:45-10:10

Title: A Cell Penetrating Peptide – Fused c-Myc Inhibitory Polypeptide Accumulates in Brain Tumors in Rats and Inhibits Tumor Growth
Dr. Drazen Raucher, Associate Professor, Department of Biochemistry, University of Mississippi Medical Center, USA

10:10-10:25

Coffee Break

10:25-10:50

Title: Potential Role of HDAC Inhibitors in Cancer Therapy. Insights into Oral Squamous Cell Carcinoma
Dr. Iglesias-Linares, Professor, US School of Medicine and Dentistry, Spain

Track 1-13: Rectum, Liver, Cholecyst and Pancreatic Cancer

Time: 8:30-09:50, June 24, 2010 (Thursday)     Place: Conference Hall B, 2F

Session Chair

Dr. Frank Gansauge, Centre of Oncological, Endocrine and Minimal-Invasive Surgery, Neu-Ulm, Germany

Session Co-Chair

Dr. Georgios Tsoulfas, Assistant Professor of Surgery, Aristoteleion University of Thessaloniki, Greece

08:30-08:50

Title: Honokiol Inhibits Tumor Growth and Metastasis via Suppressing Pkc/Mek/Erk-Dependent Matrix Metalloproteinase-9 Activation in Hepg2 Xenograft Model
Dr. Lijuan Chen,Professor, State Key Laboratory of Biotherapy, West China Hospital; West China Medical School, Sichuan University, China

08:50-09:10

Title: Surgical Therapies for Hepatocellular Carcinoma, including Laparoscopic Liver Resection
Dr. Georgios Tsoulfas, Assistant Professor of Surgery, Aristoteleion University of Thessaloniki, Greece

09:10-09:30

Title: Supplementary Immunotherapy in stage IV Pancreatic Cancer Patients with Antigen-loaded Dendritic Cells
Dr. Frank Gansauge, Center for Oncological, Endocrine and Minimal-invasive Surgery, Germany

09:30-09:50

Title: Hepatocellular Carcinoma (HCC); Current and Future Therapy
Dr. Asem Ahmed Elfert, Associate Professor, Department of Tropical Medicine and Infectious Diseases, Tanta University Faculty of Medicine, Egypt

Track 1-14: Lymphoma and Melanoma

Time: 08:30-9:10, June 24, 2010 (Thursday)    Place: Conference Hall C, 2F

Session Chair

Dr. Rachel Haywood, Group Leader (Skin Cancer Research), RAFT Institute, Mount Vernon Hospital, UK

08:30-08:50

Title: UVA-induced Melanin-associated DNA Radicals in Pigmented Melanoma Cells and Relevance to Ascorbate-modulated Hydrogen-peroxide Induced Cell Death
Dr. Rachel Haywood, Group Leader (Skin Cancer Research), RAFT Institute, Mount Vernon Hospital, UK

08:50-09:10

Title: Mechanisms Related to The Limited Success of Chemotherapy in Metastatic Malignant Melanoma
Dr. Albert Ruebben, Professor, Department of Dermatology, University Hospital RWTH, Germany

Track 1-15: Skin Cancer and Sarcomas

Time: 13:30-14:30, June 24, 2010 (Thursday)    Place: Conference Hall A, 2F

Session Chair

Dr. Christopher Poremba, Professor of Pathology and Molecular Pathology, Center of Histopathology, Cytology and Molecular Diagnostics (CHCMD) Trier, Research Park Trier, Germany

13:30-13:50

Title: Diagnosis, Therapy Prediction and Prognosis in Sarcomas: The Role of Pathology and Molecular Pathology
Dr. Christopher Poremba, Professor of Pathology and Molecular Pathology, Center of Histopathology, Cytology and Molecular Diagnostics (CHCMD) Trier, Research Park Trier, Germany

13:50-14:10

Title: Skin Tissue Infrared Microspectroscopy in the Detection of Cancer and Cancer Progression
Dr. Natalja Skrebova Eikje, Executive Director, MC Professional OÜ, Estonia

14:10-14:30

Title: Innovative and Emerging Treatments for Non-melanoma Skin Cancers
Dr. Susan Y. Chon, Assistant Professor, UT M.D. Anderson Cancer Center, Department of Dermatology, USA

Track 1-16: Leukemia and Myelodysplasia

Time: 13:30-15:10, June 24, 2010 (Thursday)     Place: Conference Hall B, 2F

Session Chair

Dr. C. Cameron Yin, Department of Hematopathology, The University of Texas M.D Anderson Cancer Center, USA

13:30-13:50

Title: Treatment with Stem Cell Differentiation Stage Factors of Hepatocellular Carcinoma in Intermediated -Advanced Stage: The Results of a Clinical Trial
Dr. Alberto Frosi, Sesto S. G. Hospital, Istituti Clinici di Perfezionamento, Italy

13:50-14:10

Title: High Resistance of CML Patients in Qatar to Imatinib Mesylate is not Related to BCR-ABL Kinase Domain Mutations: Outcome and Research Opportunities in Qatar
Dr. Hisham Morsi, Head of research & Education, School of Life Sciences, Kingston University, UK

14:10-14:30

Title: Investigation of Virus in Guthrie Cards from Children Who Develop Acute Lymphoblastic Leukaemia (ALL)
Dr. Britt Gustafsson, Associate Professor, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden

14:30-14:50

Title: Jak2 Regulates Bcr-Abl Signaling in Chronic Myeloid Leukemia
Dr. Ajoy K Samanta, Assistant Professor, Molecular Pathology, The University of Texas M.D Anderson Cancer Center, USA

14:50-15:10

Title: Mechanisms of Imatinib Resistance and Molecular Monitoring of Responses to Therapy in Chronic Myelogenous Leukemia
Dr. C. Cameron Yin, Department of Hematopathology, The University of Texas M.D Anderson Cancer Center, USA

15:10-15:25

Coffee Break

Track 1-17: Chest, Bone, and Soft Tissue Cancers

Time: 14:30-16:05, June 24, 2010 (Thursday)     Place: Conference Hall A, 2F

Session Chair

Dr. Christopher Poremba, Professor of Pathology and Molecular Pathology, Center of Histopathology, Cytology and Molecular Diagnostics (CHCMD) Trier, Research Park Trier, Germany

14:30-14:50

Title: Diagnostical  Algorithm( Steps) in Bone Tumors ( When or Who Should Perform Biopsy)
Dr. Kaan Erler, Professor, Anadolu Medical Center, Oncology Institute, Turkey

14:50-15:10

Title: Amputation Versus Limb Salvage in Musculoskeletal Sarcomas
Dr. Masood Umer, Associate professor, orthopedics, Aga khan university, Pakistan

15:10-15:25

Coffee Break

15:25-15:45

Title: Cancer Stem Cells in Sarcomas: Role in Drug Resistance and Tumor Progression
Dr. Kanya Honoki, Assistant Professor, Department of Orthopedic Surgery, Nara Medical University, Japan

15:45-16:05

Title: JAKs and PI3-K/Akt Signal Crosstalk in MC3t3-e1 OsteoblasticCells was Activated for Their Optimal  Proliferation by Conditioned Media from Osteosarcoma Cells
Dr. Kanji Mori, Assistant Professor, Department of Orthopaedic Surgery, Shiga University of Medical Science, Japan

Track 1-18: Clinical Progress in Urology, Kidney/Renal Cancer

Time: 16:05-16:45, June 24, 2010 (Thursday)     Place: Conference Hall B, 2F

Session Chair

Dr. Alexander Bachmann, Professor, University Hospital Basel, Switzerland

Session Co-Chair

Dr. Giuseppe Simone, Department of Urology, “Regina Elena” National Cancer Institute; Department of Urology, University Magna Graecia of Catanzaro, Italy

16:05-16:25

Title: The Development Of Radiotherapy In Urological Cancers
Dr. Wojciech Majewski, Assistant Professor, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Poland

16:25-16:45

Title: Tumor Biomarkers of the Prostate Versus Obesity and Insulin Resistance among Adult Arab Men
Dr. Shaun Sabico, Chief Statistician and Scientific Editor, Biomarkers Research Program, King Saud University, Saudi Arabia

Track 2-1: Cancer Epidemiology, Biostatistics and Prevention

Time: 13:10-17:25, June 22, 2010 (Tuesday)     Place: Conference Hall C, 2F

Session Chair

Dr. Jeffrey T. Holt, Professor of Pathology, Commonwealth Medical College, Scranton PA, USA

Session Co-Chair

Dr. Ashis Basu, Professor of Chemistry, University of Connecticut, USA

13:10-13:30

Title: Personalized Genetic Medicine: Scientific Rational Therapy Based on BRCA Gene Knowledge
Dr. Jeffrey T. Holt, Professor of Pathology, Commonwealth Medical College, Scranton PA, USA

13:30-13:50

Title: DNA Damage: A Central Issue in Cancer Etiology and Treatment
Dr. Ashis Basu, Professor of Chemistry, University of Connecticut, USA

13:50-14:10

Title: Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Analysis for 7-Carboxymethylguanine and 7-Carboxyethylguanine in Human Liver DNA
Dr. Mingyao Wang, Research Associate Professor, Masonic Cancer Center, University of Minnesota, USA

14:10-14:30

Title: Telomere and Cancer: Cause or Consequence?
Dr. Lifang Hou, Assistant Professor, Feinberg School of Medicine, Northwestern University, USA

14:30-14:50

Title: Carboxypeptidase-D and Nitric Oxide Production for Survival of Cancer Cells
Dr. Catherine K. L. Too, Professor, Department of Biochemisty & Molecular Biology, Dallhousie University, Canada

14:50-15:10

Coffee Break

15:10-15:25

Title: Vitamin D Receptor Genes Polymorphisms and Risk for BCC Development
Dr. Joanna Narbutt, Associate Professor, Department of Dermatology, Medical University of Lodz, Poland

15:25-15:45

Title: Expression of Vitamin D Receptor in UV Irradiated Skin and Basal Cell Carcinoma
Dr. Aleksandra Lesiak, Adjunct, Department of Dermatology Medical University of Lodz, Poland

15:45-16:05

Title: Epidemiology and Risk Factors Associated with Hepatocellular Carcinoma in a Mediterranean Population
Dr Polyxeni Agorastou, Department of Gastroenterology, Aristoteleion University of Thessaloniki, Greece

16:05-16:25

Title: Use of Natural Compounds for the Control of Tumor Development
Dr. Krishna P. Gupta, Assistant Director, Carcinogenesis Laboratory, Indian Institute of Toxicology Research, India

16:25-16:45

Title: Epidemiology of Breast Cancer in the GCC
Dr. Ali Al-Zahrani, Health Ministers’ Council for Cooperation Council States, Saudi Arabia

16:45-17:05

Title: The Good, the Bad and the Ugly: Modifiable risk factors for colorectal cancer
Dr. Alireza Ansary-Moghaddam, Health Promotion Research Center, Zahedan University of Medical Sciences, Iran

17:05-17:25

Title: An Innovative Case-spouse Control Design in Practice: An Experience in Estimating Smoking and All Cause Deaths in Chinese Adults
Dr. Jingmei Jiang, Professor, Institute of Basic Medical Sciences,  Chinese Academy of Medical Sciences, China 

Track 2-2: Molecular and Cell Oncology（Part I）

Time: 13:30-16:45 June 22, 2010 (Tuesday)    Place: Conference Hall D, 2F

Session Chair

Dr. Hui-Kuan Lin, Assistant Professor, Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, USA

Session Co-Chair

Dr. Wael M. ElShamy, Assistant Professor of Pathology, John A. Burns School of Medicine, University of Hawaii and Cancer Research Center of Hawaii, USA

13:30-13:50

Title: Parent Essential Fatty Acids , Oxygenation, and Cancer Prevention: A New Epigenetic Solution
Dr. Brian Scott Peskin, Chief Research Scientist, Cambridge International Institute for Medical Science, USA

13:50-14:10

Title: Development of a Human Tumor Tissue Culture System That Mimics Nitric Oxide Synthase Expression in Human Tumors
Dr. James A. Radosevich, Professor, Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago, USA

14:10-14:30

Title: Novel Tumor Suppressors in Translational Machinery
Dr. Sunghoon Kim, Professor and Director, Department of Molecular Medicine and Biopharmaceutical Sciences, Center for Medicinal Protein Network and Systems Biology, Seoul National University, Korea

14:30-14:50

Title: Alteration of Lipid Metabolism in Cancer. Identification of New Therapeutic Metabolic Targets
Dr. Jean-Sébastien Annicotte, Research Manager at INSERM, Inserm U896, Montpellier Cancer Research Institute, France

14:50-15:10

Title: Ubiquitination Orchestrates Akt Signaling Activation
Dr. Hui-Kuan Lin, Assistant Professor, Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: 'Rotation/twist' Model for the Molecular Mechanism of the EGF/  ErbB Receptor Family Activation
Dr. Ichiro Maruyama, Senior Investigator, Okinawa Institute of Science and Technology, Japan

15:45-16:05

Title: Targeting of Novel Molecules to Inhibit Breast Cancer Metastasis
Dr. Wael M. ElShamy, Assistant Professor, John A. Burns School of Medicine, University of Hawaii and Cancer Research Center of Hawaii, USA

16:05-16:25

Title: Protein Tyrosine Kinase: Mutational Analysis and Functional Characterization
Dr. Chua Boon Tin, Project Leader, Singapore OncoGenome Programme, Institute of Medical Biology, Singapore

16:25-16:45

Title: Anti-Oncogenic Potential of Dipeptidyl Peptidase-Iv in Human Glioblastoma
Dr. Aleksi Sedo, Professor, Institute of Biochemistry and Experimental Oncology, Faculty of Medicine of Charles University, Charles University, Czech Republic

Track 2-2: Molecular and Cell Oncology（Part Ⅱ）

Time: 15:25-17:05 June 22,2010 (Tuesday)   Place: Conference Hall E, 2F

Session Chair

Dr. Shaun R. McColl, Professor, Chemokine Biology Laboratory, School of Molecular & Biomedical Science , The University of Adelaide, Australia

Session Co-Chair

Dr.Zhixiang Wang, Professor, Department of Cell Biology, University of Alberta, Canada

15:25-15:45

Title: High Resolution Cell Cycle and Ploidy Analysis in Tissues: A Valuable Tool for the in vivo Analysis of Experimental Animal Models and Patient Biopsies
Dr. Daniel Speidel,  Group Leader, Cancer Institute NSW Fellow, Children's Medical Research Institute, Cell Transformation Unit, Australia

15:45-16:05

Title: The Chemokine Receptors CXCR4 and CCR7 Prevent Anoikis in Metastatic Cancer Cells
Dr. Shaun R. McColl, Professor, Chemokine Biology Laboratory, School of Molecular & Biomedical Science , The University of Adelaide, Australia

16:05-16:25

Title: Regulation of EGF Receptor Signaling and Endocytosis at M Phase and the Implication in Cancer Therapy
Dr.Zhixiang Wang, Professor, Department of Cell Biology, University of Alberta, Canada

16:25-16:45

Title: MicroRNA-124a: A Master Regulator of Glioblastoma Migration
Dr. Kerrie McDonald, Laboratory Head, Neuro-oncology, Prince of Wales Clinical School-Lowy Cancer Research Centre, University of NSW, Australia

16:45-17:05

Title: Regulation of Endoplasmic Reticulum Stress Response by Bioactive Compounds in HeLa Cells
Dr. Ramida Watanapokasin, Associate Professor, Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Thailand

Track 2-3: Cancer Genomics, Genetics, Epigenetics and System Biology

Time: 8:30-11:05 June 23, 2010 (Wednesday)    Place: Conference Hall B, 2F

Session Chair

Dr. Bernard Bihain, President, Genclis SAS, France

Session Co-Chair

Dr. Vladimir A. Kuznetsov, Professor, Bioinformatics Institute, Singapore

8:30-8:50

Title:Increased Transcription Infidelity in Cancer Deregulates Humoral Immunity Leading to Breast and Lung Cancer Diagnosis
Dr. Bernard Bihain, President, Genclis SAS, France

8:50-9:10

Title: Discovery of Survival Significant Genes Grouping Breast Cancer Patients
Dr. Vladimir A. Kuznetsov, Professor, Bioinformatics Institute, Singapore

9:10-9:30

Title: Genome-wide Identification of Long Noncoding RNAs in Undifferentiated and Retinoic Acid-differentiated Human Neuroblastoma Cells
Dr. Igor V. Kurochkin, Principal Investigator, Genome and Gene Expression Data Analysis Division, Bioinformatics Institute (BII), A*STAR (Agency for Science, Technology and Research), Biopolis, Singapore

9:30-9:50

Title: Retrotransposon, L1, is Probably a Culprit for Tumorigenesis in Genomics
Dr. Yunfeng Zhu, Professor, Affiliated Hospital in Academy of Military Medical Sciences, China

9:50-10:10

Title:  Molecular Profiling Identifies Novel Candidate Genes for Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
Dr. Faisal M. Fadlelmola, Lecturer, Senior Biomedical Scientist & Chartered IT Professional Fellow, School of Medicine, University of Botswana, Botswana

10:10-10:25

Coffee Break

10:25-10:45

Title: Three Epigenotypes of Colorectal Cancer Revealed by Epigenotyping through Quantitative DNA Methylation Analysis
Dr. Atsushi Kaneda, Associate Professor, Genome Science Division, RCAST, The University of Tokyo, Japan

10:45-11:05

Title: Regulation of Cell Shape, Wing Hair Initiation and the Actin Cytoskeleton by Trc/Fry and Wts/Mats Complexes
Dr. Xiaolan Fang, Research Associate, Department of Biology, University of Virginia, USA

Track 2-4: Hematology-Oncology

Time: 11:05-11:45 June 23, 2010 (Wednesday)    Place: Conference Hall B, 2F

Session Chair

Dr. Allan S.Y. Lau, Professor, Cytokine Biology Group, Department of Paediatrics and Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Session Co-Chair

Dr. Sung-Hsin Kuo, Assistant Professor, Department of Internal Medicine and Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taiwan

11:05-11:25

Title: Mechansims Underlying Epstein-Barr Virus Lmp-1-induced Cytokine Dysregulation and their Effects on Evasion of Immune Response
Dr. Allan S.Y. Lau, Professor, Cytokine Biology Group, Department of Paediatrics and Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

11:25-11:45

Title: The Biologic Significance of BCL10 Nuclear Localization in Hematologic Malignancies
Dr. Sung-Hsin Kuo, Assistant Professor, Department of Internal Medicine and Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taiwan

Track 2-5: Tumor Virology

Time: 13:30-14:10 June 23, 2010 (Wednesday)    Place: Conference Hall C, 2F

Session Chair

Dr. Maurizio Provenzano, Head of Urological Research and Laboratory for Urologic Oncology, Clinic of Urology and Division of Surgical Research,  University and University Hospital of Zurich, Switzerland

13:30-13:50

Title: Polyomavirus Bk L-Tag Specific Immune Regulatory Activity Correlates With L-Tag Positive Cancer Lesions and Biochemical Recurrence In Prostate Cancer Patients
Dr. Maurizio Provenzano, Head of Urological Research and Laboratory for Urologic Oncology, Clinic of Urology and Division of Surgical Research,  University and University Hospital of Zurich, Switzerland

13:50-14:10

Title: Insights into the Pathogenesis of Human Herpesvirus 8 (HHV8)-Driven Lymphomas
Dr. Luigi Chieco-Bianchi, Professor, Department of Oncology and Medical Sciences, University of Padova, Italy

Track 2-6: Tumor Immunology and Immunotherapy

Time: 09:10-11:25 June 24, 2010 (Thursday)    Place: Conference Hall C, 2F

Session Chair

Dr. T.-C. Wu, Professor, Departments of Pathology, Oncology, Obstetrics and Gynecology and Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, USA

Session Co-Chair

Dr. Sara I. Pai, Assistant Professor, Otolaryngology-Head & Neck Surgery and Head and Neck Cancer Research Division, Johns Hopkins Hospital, USA

09:10-09:30

Title: Antigen Specific Cancer Immunotherapy for Gynecological Malignancies
Dr. T. C. Wu, Professor, Departments of Pathology, Oncology, Obstetrics and Gynecology and Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, USA

09:30-09:50

Title: Characterization of the Tumor Microenvironment of Human Papilloma Virus Associated Head and Neck Cancers
Dr. Sara I. Pai, Assistant Professor, Otolaryngology-Head & Neck Surgery and Head and Neck Cancer Research Division, Johns Hopkins Hospital, USA

09:50-10:10

Title: Anti-CTLA-4 Antibody: A New Experimental Immunotherapy for Melanoma
Dr. Tina Cheng, Assistant Professor, Tom Baker Cancer Centre, University of Calgary, Canada

10:10-10:25

Coffee Break

10:25-10:45

Title: Combining TLR Agonists and Cell Costimulation Eradicates Established Tumors in Mice
Dr. Michael H. Kershaw, Associate professor, Laboratory Head Cancer Immunotheraphy Research, Peter MacCallum Cancer Centre, Australia

10:45-11:05

Title: Chemotherapy Enhances Antigen-specific Immunity of Cancer Vaccine through Anti-angiogenesis and Suppressing Regulatory T Lymphocytes
Dr. Wen-Fang Cheng, Associate Professor, Graduate Institute of Oncology, Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taiwan

11:05-11:25

Title: Immunotherapy of Cancer Employing Gene Modified Efector T Cells
Dr. Zelig Eshhar, Professor, Department of Immunology, The Weizmann Institute of Science, Israel

Track 2-7: Cancer/Tumor Adhesion, Migration, Invasion, and Metastasis

Time: 8:30-12:05 June 24, 2010 (Thursday)    Place: Conference Hall D, 2F

Session Chair

Dr. Shuen-Kuei Liao, Professor, Chang Gung University, Taiwan

Session Co-Chair

Dr. Rishab K. Gupta, Chief Scientific Officer, NeoGenix Oncology, Inc. USA

8:30-8:50

Title: Molecular Events Associated with Epithelial-mesenchymal Transition of Nasopharyngeal Carcinoma Cells in the Absence of Epstein-barr Virus Genome
Dr. Shuen-Kuei Liao, Professor, Chang Gung University, Taiwan

8:50-9:10

Title: Targeting of Cancer Invasion and Metastasis by a Novel Sialyltransferase Inhibitor
Dr. Wen-Chun Hung, Professor, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan   

9:10-9:30

Title: Pterostilbene Inhibits TPA-induced Invasion and Metastasis of Human Hepatoma Cells through Inactivating PKC, MAPK and PI3K/Akt Signal Transduction Pathway
Dr. Min-Hsiung Pan, Professor, Department of Seafood Science, National Kaohsiung Marine University, Taiwan

9:30-9:50

Title: PAK1 is a Novel Regulator of Breast Cancer Cell Migration and Invasion in Response to Prolactin
Dr. Maria Diakonova, Assistant Professor, Department of Biological Sciences, University of Toledo, USA

9:50-10:10

Title: A Novel Glycoprotein Associated with Tumor Metastasis and its Predictive Significance in Cancer Progression
Dr. Rishab K. Gupta, Chief Scientific Officer, NeoGenix Oncology, Inc. USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Acquisition of Surface CXCR4 Expression by the CD44bight/CD24dim Floating but not the CD44dim/CD24bright Adherent Subset of the CEA-Producing UP-LN1 Cell Line is Prerequisite for its Cancer Stem Cells to Migrate/Invade
Dr. Andy Shau-Bin Chou, Department of Radiology, Tzu-Chi General Hospital; Chang Gung University, Taiwan

10:45-11:05

Title: Crosstalk between Signalling Mediated through Adhesion, AR, AKT and PTEN in Prostate Cancer
Dr. Joanna Dulińska, Chair of Medical Biochemistry, Jagiellonian University Medical College, Poland

11:05-11:25

Title: Essential Role of FAK Signaling for Cancer Invasion by TNF-Alpha And IL-1-Beta
Dr. Takeshi Senga, Associate Professor, Division of Cancer Biology, Nagoya University school of Medicine, Japan

11:25-11:45

Title: TRIM16 Acts as a Tumour Suppressor in Neuroblastoma and Skin Cancer
Dr. Belamy B Cheung, Molecular Carcinogenesis Program, Children’s Cancer Institute Australia for Medical Research, Australia

11:45-12:05

Title: Effect of Pentoxifylline, A Haemorheological Agent, on Adhesion, Proliferation and Invasion in B16F10 Melanoma
Dr. R. P. Gude, Assisstant Professor, Principal Investigator, Cancer Research Institute ACTREC, Tata Memorial Centre, India

Track 2-8: Tumor Microenvironment and Therapy

Time: 13:30-15:10 June 24, 2010 (Thursday)     Place: Conference Hall C, 2F

Session Chair

Dr. Ranjana Prasad Bird, Vice President, Research, University of Windsor, Canada

Session Co-Chair

Dr. Aladar A. Szalay, University Professor, University of Wurzburg, Germany; Professor, Department of Radiation Oncology, Rebecca and John Moores Comprehensive Cancer Center, University of California, San Diego, President and CEO, Genelux Corporation, USA

13:30-13:50

Title: Detection and Therapy of Solid Tumors and Metastases with Oncolytic Vaccinia Virus Strains in Mouse Xenografts
Dr. Aladar A. Szalay, University Professor, University of Wurzburg, Germany; Professor, Department of Radiation Oncology, Rebecca and John Moores Comprehensive Cancer Center, University of California, San Diego, President and CEO, Genelux Corporation, USA

13:50-14:10

Title: The Effect of Host's Nutritional State on Tumor Development, Tumor Microenvironment and Response to Potential Therapeutic Agents : Studies in Animal Model of Colorectal Tumorigenesis
Dr. Ranjana Prasad Bird, Vice President, Research, University of Windsor, Canada

14:10-14:30

Title: Herpes Oncolytic Viral Therapy in Head and Neck Cancer
Dr. Matthew Old, Assistant Professor, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, USA

14:30-14:50

Title: New Therapeutic Strategy with Nitric Oxide Donors for Solid Cancer Therapy
Dr. Hiroyasu Yasuda, Associate Professor, Department of Clinical Application, Translational Research Center, Tohoku University Hospital, Japan

14:50-15:10

Title: Poison the Soil to Kill the Seeds: A New Targeting Anticancer Strategy
Dr. Yicheng NI, Professor, Department of Radiology, University Hospitals, University of Leuven, Belgium

15:10-15:25

Coffee Break

Track 2-9: Chromatin Regulation and Cancers

Time: 15:25-16:45 June 24, 2010 (Thursday)    Place: Conference Hall C, 2F

Session Chair

Dr. Zeng Quan Yang, Assistant Professor, Karmanos Cancer Institute, Wayne State University, USA

Session Co-Chair

Dr. France Carrier, Associate Professor, Marlene and Stewart Greenebaum Cancer Center, School of Medicine, University of Maryland, USA

15:25-15:45

Title: Development and Characterization of Novel Pro-Apoptotic Peptides Derived from Histone N-Terminal Domains
Dr. Woojin An, Professor, USC Norris Comprehensive Cancer Center, USA

15:45-16:05

Title: Functional DNA Repair Analysis: A New Paradigm for Breast Cancer Risk Detection
Dr. Lisa Wiesmüller, Professor, Department of Obstetrics and Gynaecology of the University of Ulm, Germany

16:05-16:25

Title: Histone Demethylase GASC1 in Cancer
Dr. Zeng Quan Yang, Assistant Professor, Karmanos Cancer Institute, Wayne State University, USA

16:25-16:45

Title: Inherent Epigenetic Characteristics Predispose Cancer Cells to Histone Deacetylase Inhibitors (HDACIs) Sensitization to Anticancer Drug Treatments
Dr. France Carrier, Associate Professor, Marlene and Stewart Greenebaum Cancer Center, School of Medicine, University of Maryland, USA

Track 2-10: Bioinformatics and Med-informatics in Cancer Research

Time: 10:25-11:15 June 25,2010 (Friday)    Place: Conference Hall G, 1F

Session Chair

Dr. Arek Kasprzyk, Director, Bioinformatics Operations and Principal Investigator, Ontario Institute for Cancer Research, Canada

Session Co-Chair

Dr. Chen-Hsiang Yeang, Assistant Research Fellow, Institute of Statistical Science, Academia Sinica, Taiwan

10:25-10:50

Title: International Cancer Genome Consortium - Enormous Challenges Ahead
Dr. Arek Kasprzyk, Director, Bioinformatics Operations and Principal Investigator, Ontario Institute for Cancer Research, Canada

10:50-11:15

Title: An Integrated Analysis of Molecular Aberrations in Cancer
Dr. Chen-Hsiang Yeang, Assistant Research Fellow, Institute of Statistical Science, Academia Sinica, Taipei, Taiwan

Track 2-11: Mechanisms of Resistance in Cancer Cells

Time: 8:30-9:50 June 25,2010 (Friday)    Place: Conference Hall G, 1F

Session Chair

Dr. Martin Michaelis, Dr. Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Germany

Session Co-Chair

Dr. Wen Jin Wu, Principal Investigator, Division of Monoclonal Antibodies (DMA), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), USA

8:30-8:50

Title: Oxidative Stress and Cancer
Dr. Lennart Moller, Professor, Karolinska Institutet (KI), Sweden

8:50-9:10

Title: Molecular Mechanisms Of Trastuzumab-resistance
Dr. Wen Jin Wu, Principal Investigator, Division of Monoclonal Antibodies (DMA), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), USA

9:10-9:30

Title: Studies to Understand and Overcome Chemoresistance Mechanisms in a Collection of Chemoresistant Cancer Cells
Dr. Martin Michaelis, Dr. Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Germany

9:30-9:50

Title: Molecular Aspects of Drug Resistance in Hepatocellular Carcinoma: Could MEK/ERK Targeting Regulate the Doxorubicin Chemosensitivity?
Dr. Irena Manov,Senior Investigator, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Israel

Track 2-12: Cancer Metastases Research

Time: 09:10-10:45 June 25,2010 (Friday)    Place: Conference Hall H, 1F

Session Chair

Dr. Christoph Wiesner, Professor, Medical and Pharmaceutical Biotechnology, IMC University of Applied Science, Austria

Session Co-Chair

Dr. Sabariah Abdul Rahman, Associate Professor, UPM-MAKNA Cancer Research Laboratory, Institute of Biosciences; Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia,  Malaysia

09:10-09:30

Title: Tumor Endothelial Cell-derived CXCL9 Increases Melanoma Metastasis
Dr. Christoph Wiesner, Professor,  Medical and Pharmaceutical Biotechnology, IMC University of Applied Science, Austria

09:30-09:50

Title: ER Quality Control in Cancer Metastasis
Dr. Yien Che Tsai, Research Fellow, Laboratory of Protein Dynamics and Signaling, National Cancer Institute, USA

09:50-10:10

Title: Deciphering the Spatial and Temporal Dynamics of Border Cell Migration
Dr. Anna C-C Jang, Institute of Molecular Medicine, National Cheng Kung University Medical College, Taiwan

10:10-10:25

Coffee Break

10:25-10:45

Title: MicroRNA Status in Colorectal Cancer: Therapeutic Implication
Dr. Sabariah Abdul Rahman, Associate Professor, UPM-MAKNA Cancer Research Laboratory, Institute of Biosciences; Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia,  Malaysia

Track 2-13: Surgical Oncology

Time: 08:30-09:10 June 25, 2010 (Friday)     Place: Conference Hall H, 1F

Session Chair

Dr. M. Asif Chaudry, Royal London Hospital and University College London, UK

Session Co-Chair

Dr. Rakhshanda Layeequr Rahman, Associate Professor, Surgical Oncology, Department of Surgery, Texas Tech University Health Sciences Center, USA

08:30-08:50

Title: The Role of EpCAM in Gastric Tumourigenesis: Lessons from CDH-1 Families
Dr. M. Asif Chaudry, Royal London Hospital and University College London, UK

08:50-09:10

Title: Innovation in Breast Cancer Surgery
Dr. Rakhshanda Layeequr Rahman, Associate Professor, Surgical Oncology, Department of Surgery, Texas Tech University Health Sciences Center, USA

Track 3-1: Stem Cell in Cancers

Time: 13:30-15:45, June 22, 2010 (Tuesday)     Place: Conference Hall F, 2F

Session Chair

Dr. Rajni Agarwal, Assistant Professor, Chief, Pediatric Stem Cell Transplant Program, Department of Pediatrics, Stanford School of Medicine, USA

13:30-13:50

Title: Hematopoetic Stem Cells-from Biology to Cure
Dr. Rajni Agarwal, Assistant Professor, Chief, Pediatric Stem Cell Transplant Program, Department of Pediatrics, Stanford School of Medicine, USA

13:50-14:10

Title: Dysfunction of Hippo Pathway Leads to Hepatic Oval Cell Proliferation and Tumor Development in Mice
Dr. Dae-Sik Lim, Associate Professor, CRI Center for Cell Division and Differentiation, Department of Biological Sciences, KAIST (Korea Advanced Institute of Science and Technology), South Korea

14:10-14:30

Title: Fibroblasts Isolated from Squamous Cell Carcinomas as a Niche for Squamous Cell Carcinoma Stem Cell?
Dr. Karel Smetana, Professor, Charles University in Prague, 1st Faculty of Medicine, Institute of Anatomy, Czech Republic

14:30-14:50

Title: Microenvironmental Regulation of Cancer Stem Cell Self-Renewal And Differentiation
Dr. Hexin Chen, Assistant Professor, University of South Carolina, USA

14:50-15:10

Title: Differential Destruction of Stem Cells: Implications for Targeted Cancer Stem Cell Therapy
Dr. Mary E. Sehl, Clinician-Scientist,Division of Hematology-Oncology, University of California, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Dying Intestinal Stem Cells, Good or Bad?
Dr. Jian Yu, Assistant Professor of Pathology, University of Pittsburgh Cancer Institute, Hillman Cancer Center Research Pavilion, USA

Track 3-2: RNA Technologies in Cancer Research

Time: 15:45-16:25, June 22, 2010 (Tuesday)    Place: Conference Hall F, 2F

Session Chair

Dr. Benyi Li, Assistant Professor, Kansas University Cancer Center, USA

15:45-16:05

Title: TRUE Gene Silencing: Finding Cancer Therapeutic sgRNAs
Dr. Masayuki Nashimoto, Professor, Department of Applied Life Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan

16:05-16:25

Title: Nanotech-based Targeted Prostate Cancer Therapy
Dr. Benyi Li, Assistant Professor, Kansas University Cancer Center, USA

Track 3-3: Gene, Tissue Chips, Lab-On-Chip and Microfluidics

Time: 11:25-12:05, June 23, 2010 (Wednesday)   Place: Conference Hall C, 2F

Session Chair

Dr. Xiaoyang Qi, Associate Professor, Cincinnati Children’s Hospital Medical Center University of Cincinnati College of Medicine, USA

11:25-11:45

Title: Fast Cell Identification Using On-Chip Technologies for Cancer Research, Diagnosis, and Therapy
Dr. Kenji Yasuda, Professor / Project Head, Tokyo Medical and Dental University / Kanagawa Academy of Science and Technology, Japan

11:45-12:05

Title: Microfluidic Biochip for Detection and Retrieval of Circulating Tumor Cells (CTCs)
Dr. Lim Chwee Teck, Professor, National University of Singapore, Singapore

Track 3-4: Proteomics in Cancer Research

Time: 13:30-16:05 , June 23, 2010 (Wednesday)    Place: Conference Hall D, 2F

Session Chair

Dr. Mark Willcox, Professor, Chief Scientific Officer, Institute for Eye Research, Australia

13:30-13:50

Title: Discovery of a New Prostate Cancer Cell Surface Protein
Dr. Brad Walsh, CSO, Minomic International Ltd, Australia

13:50-14:10

Title: Changes to Tear Proteome may be Associated with Breast and Prostate Cancer
Dr. Mark Willcox, Professor, Chief Scientific Officer, Institute for Eye Research, Australia

14:10-14:30

Title: Generation of VH/VHH Variable Domains of Llama Heavy Chain Antibodies Directed Agains Cancer Markers
Dr. Radovan Komel, Professor, Faculty of Medicine, University of Ljubljana, Slovenia

14:30-14:50

Title: Cataloguing the Proteome of the Cervical-Vaginal Fluid for Identification of Biomarkers for Cancers of the Female Genital Tract
Dr. Xaveer Van Ostade, Professor, University of Antwerp, Belgium

14:50-15:10

Title: Phosphoproteomics Reveals ERK MAP Kinase-Mediated Regulation of Nuclear Pore Complex Proteins
Dr. Hidetaka Kosako, Associate Professor, Institute for Enzyme Research, The University of Tokushima, Japan

15:10-15:25

Coffee Break

15:25-15:45

Title: Using Proteomic Approaches to Identify Potential Biomarkers for Prostate Cancer in Tears and Serum
Dr. Yong Li, Senior Cancer Institute NSW Research Fellow, Head of Cancer Research Program, Conjoint Senior Lecturer, The University of New South Wales, Australia

15:45-16:05

Title: Proteomics of Tears Can be Used to Detect Ocular Cancers
Dr. Roger W Beuerman, Professor, Singapore Eye Research Institute, Singapore

Track 3-5: PET in Oncology

Time: 14:10-15:30, June 23, 2010 (Wednesday)     Place: Conference Hall C, 2F

Session Chair

Dr. Yen Tzu-Chen, Professor and Chairperson, Department of Nuclear Medicine and Molecular Imaging Center ; Head and Neck Oncology Group, Chang Gung Memorial Hospital and Chang Gung University, Taiwan

Session Co-Chair

Dr. Mike Chao, Radiation Oncology Victoria, Royal Milbourne Hospital, Australia

14:10-14:30

Title: Click Chemistry-Based Development of PET Biomarkers for Cancer Imaging
Dr. Hartmuth Kolb, Vice President, Siemens Molecular Imaging Inc., USA

14:30 -14:50

Title: PET in Oncology - biological Significance of FDG-PET in Oral Cavity Cancer Patients with Pathological Neck Nodal Positive
Dr. Yen Tzu-Chen, Professor and Chairperson, Department of Nuclear Medicine and Molecular Imaging Center ; Head and Neck Oncology Group, Chang Gung Memorial Hospital and Chang Gung University, Taiwan

14:50-15:10

Title: Phase II Study of Preoperative Oxaliplatin and 5FU with Concurrent Radiotherapy in Patients with Locally Advanced Rectal Cancers
Dr. Michael Chao, Radiation Oncology Victoria, Royal Milbourne Hospital, Australia

15:10-15:30

Title: Recent Advances in PET Radiopharmaceuticals for Nuclear Oncology
Dr. Maung Maung Saw, Director, Singapore Radiopharmaceuticals Pte Ltd, Singapore

Track 3-6: Cancer Digital Imaging Technologies

Time: 09:20-10:10, June 24, 2010 (Thursday)     Place: Conference Hall E, 2F

Session Chair

Dr. Xiao Zhen Zhou, Assistant Professor, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Session Co-Chair

Dr. Baolin Zhang, Principal Investigator, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, USA

09:20-09:45

Title: Performance Comparison Between Image Cytology and Fourier Transform Infrared Spectroscopy (FTIR) Features as Diagnosis Input for Neural Network Based Cervical Cancer Screening System
Dr. Nor Ashidi Mat Isa, Associate Professor, Universiti Sains Malaysia, Malaysia

09:45-10:10

Title: Optical Nanoscopy - Methods and Applications
Dr. Lars Kastrup, Department of NanoBiophotonics, Max-Planck-Institute for Biophysical Chemistry, Germany

10:10-10:25

Coffee Break

Track 3-7: Laparoscopic Techniques in Uro-Oncology and Digestive System Cancer

Time: 15:25-16:05, June 24, 2010 (Thursday)     Place: Conference Hall B, 2F

Session Chair

Dr. Alexander Bachmann, Professor, University Hospital Basel, Switzerland

Session Co-Chair

Dr. Giuseppe Simone, Department of Urology, “Regina Elena” National Cancer Institute; Department of Urology, University Magna Graecia of Catanzaro, Italy

15:25-15:45

Title: Laparoscopic Radical Prostatectomy: Lessons We Have Learned after Nine Years of Experience
Dr. Alexander Bachmann, Head, Department of Urology, University Hospital Basel, Switzerland

15:45-16:05

Title: No Clamp Laparoscopic Partial Nephrectomy: Tailoring Technique to Tumor Feature
Dr. Giuseppe Simone, Department of Urology, “Regina Elena” National Cancer Institute; Department of Urology, University Magna Graecia of Catanzaro, Italy

Track 4-1: Functional Genomics in Cancer Drug Discovery and Development

Time: 13:30-14:10 June 22, 2010 Tuesday　 Place: Conference Hall G, 1F

Session Chair

Dr. Hendrik Luesch, Assistant Professor, Department of Medicinal Chemistry, University of Florida, Gainesville, USA

Session Co-Chair

Dr. Thomas Efferth, Professor, University of Mainz, Germany

13:30-13:50

Title: The Anticancer Acrtivity of the Anti-malarial Artesunate
Dr. Thomas Efferth, Professor, University of Mainz, Germany

13:50-14:10

Title: Functional Genomics and Proteomics with Anticancer Natural Products
Dr. Hendrik Luesch, Assistant Professor, Department of Medicinal Chemistry, University of Florida, USA

Track 4-2: Anticancer Drug Resistance and New Molecule Searching

Time: 14:20-16:15 June 22, 2010 Tuesday　Place: Conference Hall G, 1F

Session Chair

Dr. Attilio Di Pietro, First-Class CNRS Research Director, Institute of Protein Biology and Chemistry, France

Session Co-Chair

Dr. Ben C. Valdez, Assistant Professor, Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, USA

14:20-14:45

Title: The Mechanism of GST Action: Turning Anticancer Drug Resistance into Prodrug Activation
Dr. Xinhua Ji, Senior Investigator, Chief, Biomolecular Structure Section, National Cancer Institute, USA

14:45-15:10

Title: New Anticancer Drugs Selectively Targeting the ABCG2 and ABCC1 Transporters Involved in Multidrug Resistance: in Vitro and in Vivo Optimization
Dr. Attilio Di Pietro, First-Class CNRS Research Director, Institute of Protein Biology and Chemistry, France

15:10-15:25

Coffee Break

15:25-15:50

Title: Free-Radical Scavenging Properties of Lignin Anti-cancer Drugs
Dr. Bozena Kosikova, Professor, Institute of Chemistry SAS, Slovakia

15:50-16:15

Title: Combination of DNA Crosslinking Agents and Nucleoside Analogues in the Treatment of Leukemia
Dr. Ben C. Valdez, Assistant Professor, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, USA

Track 4-3: Neuro-oncological Cancer Drug Discovery

Time: 10:45-11:25, June 23, 2010 Wednesday　Place: Conference Hall C, 2F

Session Chair

Dr. Xiaoyang Qi, Associate Professor Human Genetics, Cincinnati Children’s Hospital Medical Center University of Cincinnati College of Medicine, USA

Session Co-Chair

Dr. Mojtaba Farjam, Lecturer and Research Assistant, Department of Medical Pharmacology, Shiraz School of Medicine, Shiraz University of Medical Sciences, Iran

10:45-11:05

Title: Brain-Tumor Targeting and Therapy by Saposin C-Associated Fluorescent Nanovesicles
Dr. Xiaoyang Qi, Associate Professor Human Genetics, Cincinnati Children’s Hospital Medical Center University of Cincinnati College of Medicine, USA

11:05-11:25

Title: Tumor Hypoxia & Bioreductive Anti-Cancer Agents
Dr. Mojtaba Farjam, Lecturer and Research Assistant, Department of Medical Pharmacology, Shiraz School of Medicine, Shiraz University of Medical Sciences, Iran

Track 4-4: New Cancer Biomarkers as Drug Targets

Time: 13:30-15:10, June 23,2010 Wednesday　Place: Conference Hall E, 2F

Session Chair

Dr. Kun Ping Lu, Professor, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Life Science, USA

Session Co-Chair

 Dr. Irina Banzola, Scientist, Department of Urology, University Hospital Zurich,  Switzerland

13:30-13:50

Title: Pin1 as a New Catalyst for Oncogenesis and a Novel Anticancer Target
Dr. Kun Ping Lu, Professor, Department of Medicine Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Life Science, USA

13:50-14:10

Title: A Novel Metastasis Factor of Pancreatic Cancer as a Therapeutic Target
Dr. Sang Seok Koh, Principal Investigator, Korea Research Institute of Bioscience and Biotechnology, Korea.

14:10-14:30

Title: Indoleamine 2, 3 Dioxygenase (IDO) as a Potential Biomarker for Cancer: A New Target for Prostate Cancer Therapy?
Dr. Irina Banzola, Scientist, Department of Urology, University Hospital Zurich,  Switzerland

14:30-14:50

Title: Oncogenic Function of Acid Ceramidase?
Dr. Xiang Liu, Assistant Professor, Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA

14:50-15:10

Title: Fer and FerT- Novel Targets for Colon and Liver Cancer Intervention
Dr. Uri Nir, Professor, Bar-Ilan University, Israel

15:10-15:25

Coffee Break

Track 4-5: Anticancer Drugs Targeting Protein Kinase Inhibitors

Time: 15:30-16:20, June 23, 2010 Wednesday　Place: Conference Hall C, 2F

Session Chair

Dr. Ning Xi, President, Calitor Sciences, USA

Session Co-Chair

 Dr. Ho Han Kiat,  Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore

15:30-15:55

Title: Development of Multi-Kinase Inhibitors for Cancer Therapy
Dr. Ning Xi, President, Calitor Sciences, USA

15:55-16:20

Title: Exploring Multi-kinase Targeting Inhibitors for the Treatment of Hepatocellular Carcinoma
Dr. Ho Han Kiat,  Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore

Track 4-6: Anticancer Drugs Targeting Signalling Pathways and Regulators

Time: 13:30-17:05, June 23, 2010 Wednesday　Place: Conference Hall F, 2F

Session Chair

Dr. James S. Norris, Professor, Microbiology and Immunology, Medical University of South Carolina, USA

Session Co-Chair

Dr. Yangchao Chen, Assistant Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China

13:30-13:50

Title: The Role Of Sphingolipid Metabolism In Cancer Resistance:  Development Of Drugs To Enhance Apoptosis In Resistant Cancers
Dr. James S. Norris, Professor, Microbiology and Immunology, Medical University of South Carolina, USA

13:50-14:10

Title: Gold Based Complexes that are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols
Dr Aleksandra Filipovska, Group leader, Mitochondrial Medicine and Biology, University of Western Australia and the Western Australian Institute for Medical Research, Australia

14:10-14:30

Title: Identification and characterization of specific USP7/HAUSP inhibitors 
Dr. Frederic Colland, Director, Biological Research, HYBRIGENICS, France

14:30-14:50

Title: Withanolides as a New class of Heat Shock Protein 90 Inhibitors and Anticancer Agents
Dr. Chin-Chung Wu, Professor, Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Taiwan

14:50-15:10 

Title: Targeting Raf kinase for the treatment of Head and Neck cancer
Dr. Pawan Kumar, Assistant Professor, Department of Otolaryngology - Head and Neck Surgery, The Ohio State University Medical Center, The Ohio State University Comprehensive Cancer Center, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: HB-EGF is a Novel Therapeutic Target for Ovarian Cancer: Development of an HB-EGF Inhibitor as an Anti-Cancer Drug
Dr. Eisuke Mekada, Professor, Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University, Japan

15:45-16:05

Title: Targeting EZH2/Stathmin for Cancer Therapy
Dr. Yangchao Chen, Assistant Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China

16:05-16:25

Title: PT-262, a Novel ROCK Inhibitor Induces Cytoskeleton Remodeling and Migration Inhibition
Dr. Jui-I Chao, Professor, Department of Biological Science and Technology, National Chiao Tung University, Taiwan

16:25-16:45

Title: New Therapeutic Approach for Brain Tumors: Intranasal Administration of Ras Inhibitor Perillyl Alcoho
Dr. Clovis O. Da Fonseca, Associate Professor of Neurosurgery, Department of Neurosurgery, Fluminense Federal University, Brazil

16:45-17:05

Title: Targeting Transcription Factor NF-κB for Prevention and Treatment of Cancer
Dr.Gautam Sethi, Assistant Professor, National University of Singapore, Singapore

Track 4-7: Inhibition of Metastasis to Vascular Targeting and Anti-Angiogenesis 

Time: 15:25-17:05, June 23, 2010 Wednesday　Place: Conference Hall E, 2F

Session Chair

Dr. Robert Klupacs, Managing Director & CEO, Circadian Technologies Limited, Australia

Session Co-Chair

Dr. Michael Fannon, Assistant Professor, Ophthalmology and Visual Sciences, University of Kentucky, USA

15:25-15:45

Title: Inhibition of VEGF-C a Novel Angiogenic and Lymphangiogenic Molecule as an Exciting New Paradigm in the Treatment of Solid Tumours
Dr. Robert Klupacs, Managing Director & CEO, Circadian Technologies Limited, Australia

15:45-16:05

Title: The Use of Tetrathiomolybdate in Head and Neck Cancer
Dr. Theodoros N Teknos, Professor, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus OH, USA

16:05-16:25

Title: Soluble Vascular Endotelial Growth Factor Receptor-1 (sVEGFR-1) Inhibits Angiogenesis in Chick Chorioallantoic Membrane and Affects Several Angiogenic Gene Expression
Dr. Taner Ozgurtas, Associate Professor, Department of Biochemistry, Gulhane Medical School, Turkey

16:25-16:45

Title: Regulating the Bioavailability of Growth Factors that Promote Tumor Growth and Angiogenesis
Dr. Michael Fannon, Assistant Professor, Ophthalmology and Visual Sciences, University of Kentucky, USA

16:45-17:05

Title: Angiogenesis and Tumor Progression Stimulated by a New P53 Isoform in Glioblastoma
Dr. Hugo Bernard, European Associated Laboratory University of Dundee, Department of surgery and Molecular Oncology, UK

Track 4-8: Apoptotic Inducers, Targeting Apoptosis Signaling Pathways and their Mediators  

Time: 9:50-11:50, June 24, 2010 Thursday　Place: Conference Hall B, 2F

Session Chair

Dr. Hua Lu, Daniel and Lori Efroymson Chair Professor of Oncology,Professor of Biochemistry and Molecular Biology, Simon Cancer Center, Indiana University School of Medicine, John D. Van Nuys Medical Science Building, USA

Session Co-Chair

Dr. Pin Ju Chueh, Associate Professor, Institute of Biomedical Sciences, National Chung Hsing University, Taiwan

9:50-10:10

Title: A Novel Chalcone with Potent Apoptotic Activity Through ROS Generation and GADD153 Activation
Dr. Pin Ju Chueh, Associate Professor, Institute of Biomedical Sciences, National Chung Hsing University, Taiwa

10:10-10:30

Title: Identification of small molecules that suppress tumor growth by targeting the p53 pathway
Dr. Hua Lu, Daniel and Lori Efroymson Chair Professor of Oncology,Professor of Biochemistry and Molecular Biology, Simon Cancer Center, Indiana University School of Medicine, John D. Van Nuys Medical Science Building, USA

10:30-10:50

Title: Single- and Co-application of Arsenic Trioxide (As2O3) and Cisplatin (CDDP) on Human SY-5Y Neuroblastoma Cells has Differential Effects on the Intracellular Calcium Concentration ([Ca2+](i)) and Cytotoxicity
Dr. Dietrich Büsselberg, Professor, Weill Cornell Medical College-Qatar, Germany

10:50-11:10

Title: Targeting the Translationally Controlled Tumour Protein TCTP and other Anti-Apoptotic Proteins
Dr. Ulrich-Axel Bommer, Associate Professor, Academic Leader Medical Sciences, Graduate School of Medicine, University of Wollongong, Australia

11:10-11:30

Title: Obtusilactone A and (-)-sesamin Inhibit Mitochondrial Lon Protease and Induce Apoptosis in Human Lung Cancer Cells via Activating DNA Damage Checkpoints
Dr. Alan Yueh-Luen Lee, Assistant Investigator, National Institute of Cancer Research, National Health Research Institutes, Taiwan

Track 4-9: Anticancer Drug Discovery Targeting Telomerase

Time: 8:30-9:20, June 24,2010 Thursday 　Place: Conference Hall E, 2F

Session Chair

Dr. Xiao Zhen Zhou, Assistant Professor, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Session Co-Chair

Dr. Baolin Zhang, Principal Investigator, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, USA

8:30-8:55

Title: Targeting Death Receptors in Cancer Therapy: From both Scientific and FDA Perspectives
Dr. Baolin Zhang, Principal Investigator, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, USA

8:55-9:20

Title: Telomerase Inhibitor Pinx1 is a Potent Tumor Suppressor and a New Anticancer Target
Dr. Xiao Zhen Zhou, Assistant Professor, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Track 4-10: New Anticancer Drug Discovery Targeting Cell Life Cycle

Time: 10:25-11:45, June 24, 2010 Thursday　Place: Conference Hall E, 2F

Session Chair

Dr. Pengbo Zhou, Associate Professor, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, USA

Session Co-Chair

Dr. Xin Yuan Liu, Member, Chinese Academy of Sciences (CAS); Foreign Member, National Academy of Sciences of Ukraine; Member, The Third World Academy of Sciences; Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, CAS, China

10:25-10:45

Title: Novel Antitumor Strategy
Dr. Xin Yuan Liu, Member, Chinese Academy of Sciences (CAS); Foreign Member, National Academy of Sciences of Ukraine; Member, The Third World Academy of Sciences; Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, CAS, China

10:45-11:05

Title: Manipulation of DNA Repair Threshold as a Novel Strategy against Carcinogenesis
Dr. Pengbo Zhou, Associate Professor, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, USA

11:05-11:25

Title: Carbohydrate-based anti-cancer drug discovery 
Dr. Kan Ding, Professor, Glycochemistry & Glycobiology Lab, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China

11:25-11:45

Title: Cell Penetrating Peptides -the Technology of Target Therapy
Dr. V.K.Bozhenko, Head of Lab, Department of Moscow RSC Roentgen Radiology, Russia

Track 4-11: Photodynamic Cancer Therapeutic Development

Time: 11:45-12:05, June 24,2010 Thursday　Place: Conference Hall E, 2F

Session Chair

Dr. Pengbo Zhou, Associate Professor, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, USA

Session Co-Chair

Dr. Xin Yuan Liu, Member, Chinese Academy of Sciences (CAS); Foreign Member, National Academy of Sciences of Ukraine; Member, The Third World Academy of Sciences; Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, CAS, China

11:45-12:05

Title: Targeting Photosensitisers to the Nucleus of Cancer Cells
Dr. David Jans, Senior Principal Research Fellow, Department of Biochemistry and Molecular Biology, Monash University, Australia

Track 4-12: Anticancer Gene Therapy

Time: 10:25-11:05, June 24,2010 Thursday　Place: Conference Hall F, 2F

Session Chair

Dr. Jerzy Trojan, Professor, INSERM U602, Paul Brousse Hospital and University Paris XI, France

Session Co-Chair

Dr. Chiaki Hidai, Associate Professor, Department of Biomedical Sciences, Nihon University School of Medicine, Japan

10:25-10:45

Title: Gene Therapy of Malignant Tumours Using Antisense/Triple Helix Anti IGF-I Strategy
Dr. Jerzy Trojan, Professor, INSERM U602, Paul Brousse Hospital and University Paris XI, France

10:45-11:05

Title: Enrichment of Transgene Products with a Deposition Domain from Del1 Protein
Dr. Chiaki Hidai, Associate Professor, Department of Biomedical Sciences, Nihon University School of Medicine, Japan

Track 4-13: Stem Cells and Cancer Cell Therapy 

Time: 13:30-15:10, June 24,2010Thursday　Place: Conference Hall D, 2F

Session Chair

Dr. Xiao-yan Jiang, Senior Scientist, BC Cancer Research Centre, Canada

Session Co-Chair

Dr. Sriram Bandi, Research Associate, Department of Medicine, Albert Einstein College of Medicine, USA

13:30-13:55

Title: Targeting Leukemic Stem Cells:  Challenges and Opportunities
Dr. Xiao-yan Jiang, Senior Scientist, BC Cancer Research Centre, Canada

13:55-14:20

Title: Single Circulating Cancer Cells Analysis. Raman Technology and Clinical Applications
Dr. N.M. Malara, BIONEM Laboratories, Department of Experimental Medicine, University Magna Graecia of Catanzaro, Italy

14:20-14:45

Title: Therapeutic Potential of Human Embryonic Stem Cells-Derived Fetal Liver-Like Cells in Liver Failure
Dr. Sriram Bandi, Research Associate, Department of Medicine, Albert Einstein College of Medicine, USA

14:45-15:10

Title: Functional Analyses of Transcriptome of Normal and Cml Stem/Progenitor Cells
Dr. Yun Zhao, Associate Professor, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University, P.R.China

15:10-15:25

Coffee break

Track 4-14: RNAi, siRNA and mRNA Based Anticancer Drug Discovery

Time: 15:25-16:40, June 24,2010 Thursday　Place: Conference Hall D, 2F

Session Chair

Dr. Suresh K. Alahari, Professor, Department of Biochemistry and Molecular Biology, Stanley S. Scott Cancer Center, LSU Health Science Center, USA

Session Co-Chair

 Dr. Takahiro Ochiya, Head, Section for Studies on Metastasis, National Cancer Center Research Institute, Japan 

15:25-15:50

Title: Double Stranded MicroRNAs, a kind of Potential Anti-Cancer Agents, Act Similarly to Sirnas but with Multi-Targets
Dr. Ruian Xu, Professor & Director, Engineering Research Center of Molecular Medicine Ministry of Education; Professor & Director, Institute of Molecular Medicine, Huaqiao University, China

 15:50-16:15

Title: Important Role of Microrna Cluster 23 in Breast Cancer Progression
Dr. Suresh K. Alahari, Professor, Department of Biochemistry and Molecular Biology, Stanley S. Scott Cancer Center, LSU Health Science center, USA

16:15-16:40

Title: Discovery of RNAi Drugs Targeting Cancer Stem Cells
Dr. Takahiro Ochiya, Head, Section for Studies on Metastasis, National Cancer Center Research Institute, Japan

Track 4-15: Therapeutic Antibodies

Time: 13:30-14:10, June 24,2010 Thursday　Place: Conference Hall E, 2F

Session Chair

Dr. Laurent Ducry, Group Leader Antibody-Drug Conjugates R&D Lonza Ltd. Valais Works,  Switzerland

Session Co-Chair

Dr. Takahiro Ishiguro, Pharmaceutical Research Department, Chugai Pharmaceutical Co. Ltd., Japan

13:30-13:50

Title: Manufacturing Antibody-Drug Conjugates, Potent Oncology Weapons
Dr. Laurent Ducry, Group Leader Antibody-Drug Conjugates R&D Lonza Ltd. Valais Works,  Switzerland

13:50-14:10

Title: Therapeutic Antibody Research against Multiple Myeloma
Dr. Takahiro Ishiguro, Pharmaceutical Research Department, Chugai Pharmaceutical Co. Ltd., Japan

Track 4-16: Therapeutic Cancer Vaccines

Time: 14:10-15:20,June 24, 2010 Thursday　Place: Conference Hall E, 2F

Session Chair

Dr. Haval Shirwan, Director, Molecular Immunomodulation Program, Institute for Cellular Therapeutics, Professor, Department of Microbiology and Immunology, Institute for Cellular Therapiceutics, University of Louiseville, School of Medicine, USA

Session Co-Chair

Dr. Shinichiro Akiyama, Director, Kudan Clinic Annex, Japan

14:10-14:30

Keynote speech
Title:Costimulation As A Novel Platform for The Development of Therapeutic Cancer Vaccines
Dr. Haval Shirwan, Director, Molecular Immunomodulation Program, Institute for Cellular Therapeutics, Professor, Department of Microbiology and Immunology, Institute for Cellular Therapiceutics, University of Louiseville, School of Medicine, USA

14:30-14:50

Title: Glycosidic Tn-based Cancer Vaccines Targeting Dermal Dendritic Cells Induce Potent Therapeutic Anti-tumoral Responses
Dr. Claude Leclerc, Professor, Institut Pasteur, France

14:50-15:10

Title: Clinical Responses in Patients with Gastroenterological Cancer Treated with Dendritic Cell-Based Cancer Vaccine. Preliminary Report from Multi-Institutional Retrospective Analysis
Dr. Shinichiro Akiyama, Director, Kudan Clinic Annex, Japan

15:10-15:25

Coffee Break

Track 4-17: Medicinal Chemistry in Anticancer Drug Discovery

Time: 15:25-16:45, June 24,2010 Thursday　Place: Conference Hall E, 2F

Session Chair

Dr. Qing-Bin Lu, Associate Professor, Departments of Physics, Chemistry and Biology, University of Waterloo, Canada

Session Co-Chair

Dr. Fazlul Huq, The University of Sydney, Australia

15:25-15:45

Title: From Molecular Mechanism Studies of Radiation-Induced DNA Damage to Development of Novel Anticancer Drugs for Radiotherapy of Cancer
Dr. Qing-Bin Lu, Associate Professor, Departments of Physics, Chemistry and Biology, University of Waterloo, Canada

15:45-16:05

Title:Platinums in Combination with Phyochemicals in Ovarian Cancer
Dr. Fazlul Huq, The University of Sydney, Australia

16:05-16:25

Title: DNA Structural Distortions Induced by Ruthenium-arene Anticancer Compounds
Dr. Ivano Tavernelli, Laboratory of Computational Chemistry and Biochemistry, Switzerland

16:25-16:45

Title: Thioredoxin Reductase as an Anticancer Molecular Target for Electrophilic Compounds Derived from Natural Sources
Dr. Eng-Hui Chew,  Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore

Track 4-18: Pharmacology, ADMET and Anticancer Drug Discovery

Time: 10:45-11:35, June 25,2010 Friday  　Place: Conference Hall H, 1F

Session Chair

Dr. Bruce Charles, School of Pharmacy, The University of Queensland, Pharmacy Australia Centre of Excellence (P.A.C.E.), Australia

Session Co-Chair

Dr. Pu Wang, Professor, Institute of Medicinal Chemistry, Pharmacy School, Shandong University, Shandong, China

10:45-11:10

Title: Population Pharmacokinetic Modelling of Vincristine in Young Children
Dr. Bruce Charles, Associate Professor, School of Pharmacy, The University of Queensland, Pharmacy Australia Centre of Excellence (P.A.C.E.), Australia

11:10-11:35

Title: Paclitaxel-Target Peptide Conjugates: High Effective and Low Toxic Anticancer Agents
Dr. Pu Wang, Professor, Institute of Medicinal Chemistry, Pharmacy School, Shandong University, Shandong, China

Track 4-19: Nanotechnology and Novel Drug Delivery Systems

Time: 8:30-10:10, June 25,2010 Friday　Place: Conference Hall J, 1F

Session Chair

Dr. Luigi Manzo, Professor, European Centre for Nanomedicine, Department of Internal Medicine, University of Pavia, Maugeri Foundation Medical Institute, Italy

Session Co-Chair

Dr. Naoto Oku, Dean, School of Pharmaceutical Sciences, University of Shizuoka, Professor; Department of Medical Biochemistry, University of Shizuoka School of Pharmaceutical Sciences, Japan

8:30-8:55

Title: Nanovectors: New Opportunities for Boron Neutron Capture Therapy
Dr. Luigi Manzo, Professor, European Centre for Nanomedicine, Department of Internal Medicine, University of Pavia, Maugeri Foundation Medical Institute, Italy

8:55-9:20

Title: Development of dual targeting strategy for antineovasucluar cancer therapy
Dr. Naoto Oku,Dean, School of Pharmaceutical Sciences, University of Shizuoka, Professor; Department of Medical Biochemistry, University of Shizuoka School of Pharmaceutical Sciences, Japan

9:20-9:45

Title: The Enhancement of Photodynamic Efficiency of Nano-TiO2 for LoVo Cancer Cell and Tumor by Combining with Immunity - Electroporation Technique, or Using Silver Modified Nano-Tio2 Method
Dr. Zhi yu Jiang, Professor, Department of Chemistry, Fudan University, China

9:45-10:10

Title: Gold Nano Particles Induced Apoptotic Gene Clusters via Differential Activation of WTp53 in Cancer Cells
Dr. Uttam Pati, Professor, School of Biotechnology, Jawaharlal Nehru University, India

10:10-10:25

Coffee Break

Track 4-20: Innovative Designs of Phase I/II Trials, Regulatory Issues and Translational Research

Time: 11:15-11:40, June 25,2010 Friday　Place: Conference Hall G, 1F

Session Chair

Dr. Arek Kasprzyk, Director, Bioinformatics Operations and Principal Investigator, Ontario Institute for Cancer Research MaRS Centre, Canada

Session Co-Chair

Dr. Chen-Hsiang Yeang, Assistant Research Fellow, Institute of Statistical Science, Academia Sinica, Taipei, Taiwan

11:15-11:40

Title: Novel Drug Development for Hepatocellular Carcinoma - from Mouse to Man
Dr. Toh Han Chong, Head and Senior consultant, Department of Medical Oncology, National Cancer Centre, Singapore

Track 4-21: Multi-Modal Attacks on Cancer: Focal Therapies as Immune Promoters 

Time: 8:30-10:25, June 24,2010 Thursday　Place: Conference Hall F, 2F

Session Chair:

Dr. Sy-Shi Wang, VP Clinical Development, Light Sciences Oncology, Inc., USA

8:30-8:55

Title: The Development of Light-Activated Talaporfin Sodium as Focal Therapy and Immune Promoter
Dr. Llew Keltner, CEO, Light Sciences Oncology, Inc., USA

8:55-9:20

Title: Implication of Immunologic Effects Primed by Focal Therapies
Dr. Sy-Shi Wang, VP Clinical Development, Light Sciences Oncology, Inc., USA

9:20-9:45

Title: Development of Immunotherapy Combined with in Site Tumor Destruction
Dr. Yutaka Kawakami, Professor and Director, Keio University School of Medicine, Japan

9:45-10:10

Title: Photodynamic Therapy-Mediated Anti-Tumor Immune Response
Dr. Patricia SP Thong, Research Fellow, National Cancer Centre, Singapore

10:10-10:25

Coffee Break

Track 5-1: Cancer Biomarkers, Molecular Diagnostics, Blood Tests, and Biopsy

Time: 13:30-16:05, June 22, 2010 (Tuesday)     Place: Conference Hall H, 1F

Session Chair

Dr. Christian Ensinger, Professor, Institute of Pathology, Medical University of Innsbruck, Austria

Session Co-Chair

Dr. Manish Kohli,Associate Professor, Mayo Clinic Comprehensive Cancer Center, USA

13:30-13:50

Title: Large-scale Glycomics for the Discovery of Cancer Markers: Diagnostic Mass Spectrometry Based on Glycoblotting Technology
Dr. Shin-Ichiro Nishimura,Professor, Hokkaido University, Japan

13:50-14:10

Title: Stress-Induced Phosphoprotein 1 as a Biomarker for Human Ovarian Cancer
Dr. Angel Chao, Physician scientist, Chang Gung Memorial Hospital, Taiwan

14:10-14:30

Title: Genomic Predictors of Androgen Deprivation Therapy (ADT) Response in Advanced Prostate Cancer
Dr. Manish Kohli,Associate Professor, Mayo Clinic Comprehensive Cancer Center, USA

14:30-14:50

Title: Cytodiagnostic Aspects of the Thyroid Neoplasms: The Current Scenario
Dr. Neelaiah Siddaraju, Professor of Pathology, Jawaharlal Institute of Postgraduate Medical Education and research (JIPMER), India

14:50-15:10

Title: Changes in Pathological Diagnosis from Histopathology to Molecular Investigations in Cancer Treatment
Dr. Christian Ensinger, Professor, Institute of Pathology, Medical University of Innsbruck, Austria

15:10-15:25

Coffee Break

15:25-15:45

Title: DNA Sequence Analysis in a Molecular Diagnostics Laboratory: Clinical Utility and Techniques
Dr. Su S. Chen, Assistant Professor, Molecular Diagnostics Laboratory, Hematopathology Department, The University of Texas M. D. Anderson Cancer Center, USA

15:45-16:05

Title: Diagnosis of Intrahepatic Metastasis and Multicentric Carcinogenesis by Microsatellite Analysis in Patients with Recurrent Hepatocellular Carcinoma
Dr. Yuki Sakuraoka, Investigator, Department of Gastroenterological Surgery, Dokkyo University School of Medicine, Japan

Track 5-2: Cancer Pathology and Imaging: From Biochemical Analysis to Diagnostic Tool

Time: 16:05-17:05, June 22, 2010 (Tuesday)    Place: Conference Hall H, 1F

Session Chair

Dr. Takuma Hayashi, Associate Professor, Shinshu University Medical School, Japan

16:05-16:25

Title: Alternative Representatives for Clinical Slow / Fast Diffusion Tensor Imaging
Dr. Archie Chu, Assistant Professor, Clinical Medical Physicist, Yale University School of Medicine; Yale New Haven Hospital, USA

16:25-16:45

Title: Establishment of Diagnostic Biomarker Against Uterine Leiomyosarcoma for Development of Diagnosis and Anti-tumor Drug
Dr. Takuma Hayashi, Associate Professor, Shinshu University Medical School, Japan

16:45-17:05

Title: Detection of Fecal Occult Blood for Colon Cancer by Matrix-assisted Laser Desorption/Ionization Time-of-Llight Mass Spectrometry
Dr. Jentaie Shiea, Professor, Department of Chemistry, National Sun Yat-Sen University, Taiwan

Track 5-3: Cancer Genetic Screening and Prognosis

Time: 8:30-9:10, June 23, 2010 (Wednesday)     Place: Conference Hall C, 2F

Session Chair

Dr. Jason Halsey, VP of Scientific Operations, Molecular Biology Systems Division, Life technologies, USA

8:30-8:50

Title: Rare Mutation and Early Cancer Detection by CastPCR
Dr. Jason Halsey, VP of Scientific Operations, Molecular Biology Systems Division, Life Technologies, USA

8:50-9:10

Title: Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
Dr. Kyoko Yorozuya, Assistant Professor, Division of Breast and Endocrine Surgery, Department of Surgery, Aichi Medical University, Japan

Track 5-4: Nuclear Medicine and Diagnosis

Time: 9:10 -10:45, June 23, 2010 (Wednesday)     Place: Conference Hall C, 2F

Session Chair

Dr. Mian Alauddin, Associate Professor, The University of Texas M. D. Anderson Cancer Center, USA

9:10-9:30

Title: Perfusion MR Imaging for Assessment of Brain Metastases Response to whole Brain Radiation Therapy
Dr. Augusto Elias Mamere, Chairman, Department of Radiology and Diagnostic Imaging, Barretos Cancer Hospital, Brazil

9:30-9:50

Title: Evolution of Functional Imaging in the Management of Breast Cancer : Impact of PET-CT and the Lessons Learnt
Dr. Partha S. Choudhury, Chief of Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Centre, India

9:50-10:10

Title: [1-11C]-acetate PET in Head and Neck Cancer Patients: for Staging, Delineating Target Volume and Characterizing Tumor Oxidative Metabolism and Perfusion
Dr. Aijun Sun, Assistant Professor, Chief of PET Center, Zibo Wanjie Oncology Hospital, China

10:10-10:25

Coffee Break

10:25-10:45

Title: Combined PET/CT-perfusion: Extended Possibilities in Therapy Response Evaluation
Dr. Patrick Veit-Haibach, Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, Switzerland

Track 5-5: Immunohistochemical Diagnosis of Cancer

Time: 13:30-14:10, June 23, 2010 (Wednesday)    Place: Conference Hall G, 1F

Session Chair

Dr. Dave S. B. Hoon, Director, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, USA

13:30-13:50

Title: Immunohistochemistry And Beyond In The Management of Renal Cell Carcinoma
Dr. Pheroze Tamboli, Associate Professor of Pathology, Department of Pathology, Anderson Cancer Center, USA

13:50-14:10

Title: Immunohistochemical Studies in the Diagnosis, Prognosis, and Therapy of Acral Lentiginous Melanoma
Dr. Carlos A. Torres-Cabala, Assistant Professor,The University of Texas M. D. Anderson Cancer Center, USA

Track 5-6: DNA Level in Blood and Stool in Cancer Diagnosis

Time: 14:10-15:10, June 23, 2010 (Wednesday)     Place: Conference Hall G, 1F

Session Chair

Dr. Dave S. B. Hoon, Director, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, USA

14:10-14:30

Title: Prognostic Clinical Utility of Different Forms of Circulating Tumor-Related DNA in Cancer Patients Blood
Dr. Dave S. B. Hoon, Director, Department of Molecular Oncology, John Wayne Cancer Institute, USA

14:30-14:50

Title: New Methods for Colorectal Cancer Diagnosis Using Colonocytes Isolated from Natural Evacuated Feces
Dr. Yoshikatsu Koga, Research Fellow, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Japan

14:50-15:10

Title: The Role of Plasma EBV-DNA in Nasopharyngeal Carcinoma
Dr. Patrick Lau, Specialist in Medical Oncology, Honorary Clinical Tutor, The Chinese University of Hong Kong, China

Track 5-7: Robotics and Tumor Mini-invasive Therapy

Time: 11:05-12:05, June 24, 2010 (Thursday)    Place: Conference Hall F, 2F

Session Chair

Dr. Jerzy Trojan, Professor, INSERM U602, Paul Brousse Hospital and University Paris XI, France

Session Co-Chair

Dr. Chiaki Hidai, Associate Professor, Department of Biomedical Sciences, Nihon University School of Medicine, Japan

11:05-11:25

Title: Intrafraction Robotic Ultrasound Guided Radiation Therapy
Dr. Christian M Langton, Professor, Queensland University of Technology, Australia

11:25-11:45

Title: Ultrasound and Dye Assisted Surgery (USDAS) for Head and Neck Cancer
Dr. Enrica Grosso, Assistant, Division of Head and Neck Surgery, European Institute of Oncology, Italy

11:45-12:05

Title: Virtual Reality for Minimally Invasive Surgery
Dr. Stephane Nicolau, Director of Medical Imaging Team, IRCAD Research Institute Against Abdominal Cancer, Taiwan

Track 5-8: Radiotherapy and Medical Device Therapy for Cancer

Time: 8:30-11:25, June 24,2010 (Thursday)     Place: Conference Hall G, 1F

Session Chair

Dr. Jun Deng, Associate Professor, Department of Therapeutic Radiology, Yale University School of Medicine, Yale New Haven Hospital, USA

Session Co-Chair

Dr. Joao Seco, Assistant Professor of Radiation Oncology, Harvard Medical School, Francis H Burr Proton Center, Massachusetts General Hospital, USA

8:30-8:50

Title: Image Gently for Pediatric Cancer Patients in the Era of Image-Guided Radiation Therapy
Dr. Jun Deng, Associate Professor,Department of Therapeutic Radiology, Yale University School of Medicine, USA

8:50-9:10

Title: Experience in Implementation and Clinical Applications of a New Volumertric Intensity Modulated Arc Therapy Treatment Technique (VIMAT) for Head and Neck Cancers
Dr. Chau Ming-Chun, Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China

9:10-9:30

Title: Combination Treatment with Arsenic Trioxide and Irradiation Induces Autophagy and Apoptosis through Inhibition of AKT and Enhanced ERK1/2 Activity in HT1080 Human Fibrosarcoma Cells
Dr. Wang Ying-Jan, Professor, Department of Environmental and Occupational Health, National Cheng Kung University, Medical College, Taiwan

9:30-9:50

Title: An Evaluation Effectiveness and Toxicity of Half-Body Irradiation (HBI) as the Treatment of Cancer Patients with Multiple, Painful Bone Metastases
Dr. Leszek Miszczyk, Professor of Oncology, Radiotherapy Department, Centre for Oncology, M. Sklodowska-Curie Memorial Institute, Poland

9:50-10:10

Title: Animal Models of Locoregional Radionuclide Cancer Therapy: Rats and Dogs
Dr. Franklin C. Wong, Professor of Nuclear Medicine and Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: AvidinOX™ for Pre-Targeted Radionuclide Therapy
Dr. Rita De Santis, Head Immunology and Biotechnology Development, Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Italy

10:45-11:05

Title: Image Guided Adaptive Radiation/Hadron Therapy: Advanced Technologies for High Biological and Geometrical Selectivity in Cancer Local Treatment
Dr. Maria Francesca Spadea, Assistant Professor, Magna Graecia University, Italy

11:05-11:25

Title: The Reduction of Metal Artifact Effects in CT Planning in the Era of Proton Radiation Therapy
Dr. Joao Seco, Assistant Professor of Radiation Oncology, Harvard Medical School, Francis H Burr Proton Center, Massachusetts General Hospital, USA

Track 5-9: Cancer Surgery, Interventional Therapy and Symptom Management

Time: 13:30-15:30, June 24,2010 (Thursday)     Place: Conference Hall F, 2F

Session Chair

Dr. Keiichi Kubota, Professor and Chairman, Department of Gastro-Enterological Surgery, Dokkyo University School of Medicine, Japan

13:30-13:50

Title: Radio-Embolisation Using Ittrium90 (Y90) In Patients Affected by Unresectable Hepatic Metastases
Dr. Roberto Cianni,Director of Advanced Imaging and Interventional Radiology Unit, Latina General Hospital, Italy

13:50-14:10

Title: Cancer Surgery, Interventional Therapy and Symptom Management Risk Stratification in Oral Cavity Cancer - Experience from Taiwan
Dr. Liao Chun-Ta, Associate Professor and Director, Head and Neck Oncology Group, Departments of Otorhinolaryngology, Chang Gung Memorial Hospital Linkou Medical Center, Taiwan

14:10-14:30

Title: Management of Anaemia in Major Cancer Surgery– an Update
Dr. Ravishankar RaoBaikady, Consultant in Anaesthesia, The Royal Marsden NHS Foundation Trust, UK

14:30-14:50

Title: A New Inflammation-Based Prognostic Score Predicts Prognosis of Patients Undergoing Surgery for Hepatocellular Carcinoma
Dr. Keiichi Kubota, Professor and Chairman, Department of Gastro-Enterological Surgery, Dokkyo University School of Medicine, Japan

14:50-15:10

Title: The Current Status of Sentinel Node Biopsy in Melanoma
Dr. Omgo E. Nieweg, Research Fellow, Department of Surgery, The Netherlands Cancer Institute, The Netherlands

15:10-15:30

Title: Nipple-Sparing Mastectomy With or Without Radiotherapy in Advanced Breast Cancer: The First European Experience
Dr. Kris Petur Benediktsson, Associate Professor, The Karolinska Institute, Sweden

Track 5-10: Clinical Update on Combination Cancer Therapy

Time: 15:30-16:10, June 4,2010 (Thursday)      Place: Conference Hall F, 2F

Session Chair

Dr. Juergen Engel, President & CEO, Aeterna Zentaris, Germany

15:30-15:50

Title: Combination Therapies with the Multi-Targeted Akt Inhibitor Perifosine: Lessons from Multiple Myeloma and Colon Cancer Trials
Dr. Juergen Engel, President & CEO, Aeterna Zentaris GmbH, Germany

15:50-16:10

Title: Biological Oncotherapy According to The Di Bella Method (DBM), With The Synergic Use of Somatostatin and/or Octreotide, Bromocryptin and/or Cabergoline, Melatonin, Retinoids, Vitamins E, D3, and C, Chondroitin Sulfate, Calcium, and Minimal Apoptotic, Non Cytolytic Doses of Cyclophosphamide or Oncocarbide. Rationale of The DBM, and Results of 553 Cases of 29 Different Histotypes
Dr. Giuseppe Di Bella, Cancer Biotherapy, Specialist, Otolaryngology, Stomatolog, Italy

Track 6-1: Clinical Lung Cancer, Diagnostics and Treatment

Time: 8:30-9:50 June 23,2010, (Tuesday)   Place: Conference Hall F, 2F

Session Chair

Dr. Xing-Qi Lu, Chief, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, USA

Session Co-Chair

Dr. Giuseppe Mastrangelo, Associate Professor, Department of Environmental Medicine and Public Health, University of Padova, Italy

8:30-8:50

Title: Robotic Image Guided Radiation Therapy for Lung Cancer
Dr. Xing-Qi Lu, Chief, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, USA

8:50-9:10

Title: Cryotherapy in the Multidisciplinary Treatment of Lung Cancer
Dr. Vladimir Anikin, Consultant Thoracic Surgeon, Department of Thoracic Surgery, Harefield Hospital, The Royal Brompton and Harefield Hospital NHS Foundation Trust, UK

9:10-9:30

Title: Endotoxin Exposure and Lung Cancer Risk in Agriculture and Cotton Textile Workers
Dr. Giuseppe Mastrangelo, Associate Professor, Department of Environmental Medicine and Public Health, University of Padova, Italy

9-30-9:50

Title: The Maryland Lung Cancer Study: Molecular Epidemiology Of Non-Small Cell Lung Cancers, With Focus On Women And African Americans
Dr. Rex C Yung, Director of Bronchology & Pulmonary Oncology, Departments of Medicine and Oncology, Pulmonary & Critical Care Medicine, Johns Hopkins University, USA

Track 6-2: Molecular Epidemiology, Pathology and Prevention

Time: 9:50-11:45,June 23, 2010 Tuesday　Place: Conference Hall F, 2F

Session Chair

Dr. Kwang Joo Park,  Professor, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, Ajou University School of Medicine, South Korea

Session Co-Chair

Dr. Yi-Ching Wang, Distinguished Professor, Department of Pharmacology, College of Medicine, National Cheng Kung University, Taiwan

9:50-10:10

Title: Lung Cancer Risk in Sweden and USA versus Japan – a Lifestyle Matter?
Mr. Örjan Hallberg, MSEEFounder, Hallberg Independent Research, Sweden

10:10-10:25

Coffee Break

10:25-10:45

Title: Lung Cancer and Gender Differences in Pathogenesis, Response to Treatment and Prognosis
Dr. Ana Oton,Assistant Professor, University of Colorado, Denver Health Medical Center, USA

10:45-11:05

Title: Signal Pathways Involved in Tobacco Carcinogen-Induced DNA Methyltransferase 1 Accumulation in Lung Cancer
Dr. Yi-Ching Wang, Distinguished Professor, Department of Pharmacology, College of Medicine, National Cheng Kung University, Taiwan

11:05-11:25

Title:Tobacco Carcinogens, Genetic Susceptibility and Lung Cancer
Dr. Ravindran Ankathil, Professor, Human Genome Center, University Sains Malaysia, Malaysia

11:25-11:45

Title : Peroxiredoxins in Lung Cancer
Dr. Kwang Joo Park,  Professor, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, Ajou University School of Medicine, South Korea

Track 6-3: Molecular Profiling of Lung Cancer

Time: 10:45-12:05 June 23,2010 (Wednesday)    Place: Conference Hall D, 2F

Session Chair

Dr. Joanna Chorostowska Wynimko, Head of the Laboratory of Molecular Diagnostics, National Institute of Tuberculosis & Lung Diseases, Poland

Session Co-Chair

Dr. Jin Jen, Director, Microarray Shared Resources, Advanced Genomics Technology Center; Senior Associate Consultant, Department of Pulmonary and Critical Care Medicine, Mayo Clinic, USA

10:45-11:05

Title: MicroRNA Signatures in Lung Adenocarcinoma from Never Smokers
Dr. Jin Jen, Director, Microarray Shared Resources, Advanced Genomics Technology Center; Senior Associate Consultant, Department of Pulmonary and Critical Care Medicine, Mayo Clinic, USA

11:05-11:25

Title: Free Plasma DNA as a Diagnostic Tool in Lung Cancer: Prognostic and Predictive Markers
Dr. Joanna Chorostowska-Wynimko, Head of the Laboratory of Molecular Diagnostics, National Institute of Tuberculosis & Lung Diseases, Poland

11:25-11:45

Title: Altered microRNA Expression in Lung Adenocarcinoma
Dr. Ming Guo,Assistant Professor, Department of Pathology, The University of Texas M.D. Anderson Cancer Center, USA

11:45-12:05

Title: EGFR Mutations and Survival Benefit from EGFR-TKIs in Lung Cancer
Dr. Toshimi Takano, Head, Department of Medical Oncology, Toranomon Hospital, Japan

Track 6-4: NSCLC & SCLC and Interventions

Time: 08:30-09:50 June 24,2010 (Thursday)    Place: Conference Hall H, 1F

Session Chair

Dr. Majed Refai, Thoracic Surgery Department, Ospedali Riuniti (Umberto I°) Hospital, Italy

Session Co-Chair

Dr. Maya Gottfried, Head of Lung Cancer Unit, Meir Medical Center, Israel

08:30-08:50

Title: Report on the Disappearance Non-Small Cell Lung Carcinoma and Other Case Studies
Dr. T T Ang, Professor, Chinese Nature-Cure Institute, Singapore

08:50-09:10

Title: Pneumonectomy after induction therapy for stage III A non-small-cell lung cancer, a controversial issue
Dr. Majed Refai, Thoracic Surgery Department, Italy

09:10-09:30

Title:  First Line Treatment Options in NSCLC Current Target Profile in NSCLC and the Therapeutic Application
Dr. Maya Gottfried, Head of Lung Cancer Unit, Meir Medical Center, Israel

09:30-09:50

Title: Maintenance Therapy for Advanced Non-small Cell Lung Cancer - A Valuable Treatment Strategy
Dr. Ciuleanu Tudor Eliade, Associated Professor, Oncology Institute Ion Chiricuta, Romania

Track 6-5: Chemotherapy for Lung Cancer 

Time: 09:50-11:45 June 24,2010 (Thursday)    Place: Conference Hall H, 1F

Session Chair

Dr. Marianna Koczywas, Associate Professor, Department of Medical Oncology, Thoracic Oncology & Lung Cancer Program, USA

Session Co-Chair

Dr. Kaishan Liu, Associate Professor, Department of Pathology, Medical College, Jinan University, China

09:50-10:10

Title: Quality of Life and Symptom Management Barriers in Lung Cancer
Dr. Marianna Koczywas, Associate Professor, Department of Medical Oncology, Thoracic Oncology & Lung Cancer Program, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Adjuvant Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Dr. Ozden Altundag, Associate Professor, Department of Medical Oncology, Baskent University Faculty of Medicine, Turkey

11:45-11:05

Title: Neoadjuvant and Adjuvant Chemotherapy of Non-small Cell Lung Cancer
Dr. Valentina Tzekova, Professor, University Hospital “Queen Joanna”, Bulgaria

11:05-11:25

Title: 2nd-Line Chemotherapy for Small-Cell Lung Cancer
Dr. Young Hak Kim, Assistant Professor, Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan

11:25-11:45

Title: Personalized Therapy for Non-Small Cell Lung Cancer
Dr. Kaishan Liu, Associate Professor, Department of Pathology, Medical College, Jinan University, China

Track 6-6: Translational Research and Clinical Trials

Time: 16:10-17:10 June 24,2010 (Thursday)   Place: Conference Hall F, 2F

Session Chair

Dr. Wulf Dröge, Professor of Cell Biology and Immunology, Senior Scientist, Immunotec Inc., Canada

Session Co-Chair

Dr. Evgeny N Imyanitov, Head of the Department of Tumor Growth Biology, N.N. Petrov Institute of Omcology, Russia

16:10-16:30

Title: Cysteine-rich Protein Reverses Weight Loss and Improves Several Secondary Endpoints in
Lung Cancer Patients - Suggestive Evidence for the Involvement of Inflammatory Parameters
Dr. Wulf Dröge, Professor of Cell Biology and Immunology, Senior Scientist, Immunotec Inc., Canada

16:30-16:50

Title: Incorporation of EGFR Mutation Testing into Clinical Practice: Russian Experience
Dr. Evgeny N Imyanitov, Head of the Department of Tumor Growth Biology, N.N. Petrov Institute of Omcology, Russia

16:50-17:10

Title: Issues in Clinical Trials In Developing Countries
Dr. Edavalath Narayanankutty, Senior Consultant and Head, Department of Oncology, Malabar Institute of Medical Sciences, India

Track 7-1: Acute Symptom Care Oncology Nursing & Quality Care

Time: 8:30-9:30, June 23, 2010 (Tuesday)     Place: Conference Hall G, 1F

Session Chair

Dr. Chao Hsing Yeh, Associate Professor, Department of Promotion and Development, School of Nursing, University of Pittsburgh, USA

8:30-8:50

Title: Auricular Acupressure to Reduce Chemotherapy induced Nausea and Vomiting (CINV) in Children
Dr. Chao Hsing Yeh, Associate Professor, Department of Promotion and Development, University of Pittsburgh School of Nursing, USA

8:50-9:10

Title: Rational Drug Treatment and Management: the Emerging Role of the Nurse
Dr. Andreas Charalambous, Lecturer at Cyprus Technology University, Cyprus; Head of the Euro-Mediterranean Research Center for Oncology and Palliative Care, Cyprus, Visiting Lecturer at Middlesex University, UK

9:10-9:30

Title: How to Prevent and Relief of Oral Problems During Cancer Treatment
Dr. Panwadee Putwatana, Associated Professor, Department of Nursing, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand

Track 7-2: Palliative Care, Psycho-Oncology, Nutritional Protection, Pain Management

Time: 8:30-10:45, June 23, 2010 (Wednesday)    Place: Conference Hall D, 2F

Session Chair

Dr. Perry G. Fine, Professor of Anesthesiology, Pain Research Center, School of Medicine, University of Utah, USA

Session Co-Chair

Dr. Ying-hwa Su, Assistant Professor, Department of Nursing, College of Medicine, National Cheng Kung University, Taiwan

08:30-08:50

Title: The Role of Interventional Pain Therapies in Integrated Palliative Care in Cancer
Dr. Perry G. Fine, Professor of Anesthesiology, Pain Research Center, School of Medicine, University of Utah, USA

08:50-09:10

Title: Can Patients Experience Health and Believe in the Future When Imprisoned by the Emotional and Existential Burden of Cancer?
Dr. Margereth Bjorklund, Lecturer, School of Health and Society, Kristianstad University Collage, Sweden

09:10-09:30

Title: Building Community Based Systems of Care for Patients
Dr. Malene S. Davis, President &CEO, Capital Hospice, USA

09:30-09:50

Title: Living with a Prostate Cancer Diagnosis; A Qualitative Two Year Follow-Up
Dr. Annikki Jonsson, Doctor of Medicine, Department of Urology, Sahlgrenska University Hospital, Sweden

09:50-10:10

Title: The Difficulties and Educational Needs of Nursing Students and Staff in in Parent-child Communication about Parental Cancer
Dr. Ying-hwa Su, Assistant Professor, Department of Nursing, College of Medicine, National Cheng Kung University, Taiwan

10:10-10:25

Coffee Break

10:25-10:45

Title: Existential Sedation – The Challenge for TH Interdisciplinary (IDT) Team
Dr. Michaela Bercovitch, Head – Palliative Care Department “Beit Friedman”, The Chaim Sheba Medical Center; Lecturer, Sackler School of Medicine, Tel Aviv University, Israel

Track 7-3: Cancer Epidemiology, Public Healthcare, and Reimbursement Policy

Time: 15:25-15:45, June 23, 2010 (Wednesday)     Place: Conference Hall G, 1F

Session Chair

Dr. Alexandra McManus, Associate Professor, Director, Centre of Excellence for Science, Seafood & Health (CESSH), Curtin Health Innovation Research Institute (CHIRI) | Faculty of Health Sciences, Curtin University, Australia

15:25-15:45

Title: The Global Fight against Cancer: Role of the IAEA
Dr. Rethy K. Chhem, Director of the Division of Human Health, International Atomic Energy Agency, Austria

Track 8-1: Advances In Cancer Screening‎ and Monitoring

Time: 9:30-10:30, June 23,2010 (Tuesday)     Place: Conference Hall G, 1F

Session Chair

Dr. Chao Hsing Yeh, Associate Professor, Department of Promotion and Development, School of Nursing, University of Pittsburgh, USA

9:30-9:50

Title: A Mediational Model of Religious Involvement and Cancer Risk, Prevention, and Screening Behaviors in a National Sample of African Americans
Dr. Cheryl L. Holt, Associate Professor, Department of Public and Community Health, School of Public Health, University of Maryland, USA

9:50-10:10

Title: Community-based Screening for Cervical Cancer: Opportunities and Barries
Dr. Latiffah A. Latiff, Associate Professor, Coordinator for Diagnostic and Therapeutics, Laboratory for Cancer Research UPM-MAKNA, Institute of Bioscience, Malaysia

10:10-10:30

Title: The Success and Failure in U.S. Cancer Prevention Work
Dr. Fan Chen, Associate Professor, Department of Community Medicine, Mercer University School of Medicine, USA

Track 8-2: Botanical Medicine for Cancers in Clinical Practice

Time: 8:30-10:45, June 23,2010 (Wednesday)     Place: Conference Hall E, 2F

Session Chair

Dr. Elena J Ladas, Director of the Integrative Therapies Program, Division of Pediatric Oncology, Columbia University, Children's Hospital of New York, USA

Session Co-Chair

Dr. Masashi Kanai, Assistant Professor, Outpatient Oncology Unit, Graduate School of Medicine, Kyoto University Hospital, Japan

8:30-8:50

Title: Milk Thistle: A Potential Hepatoprotectant among Children Undergoing Treatment For Cancer
Dr. Elena J Ladas, Director of the Integrative Therapies Program, Division of Pediatric Oncology, Children's Hospital of New York, Columbia University, USA

8:50-9:10

Title: Phase I/II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who get Refractory to Gemcitabine-Based Chemotherapy
Dr. Masashi Kanai, Assistant Professor, Kyoto University Hospital, Japan

9:10-9:30

Title: Anti-tumor Activity of KG-135, Enriched with Selected Ginsenosides,in Xenograft Model and Its Action Mechanism
Dr. Hyun Ok Yang, Head, Natural Products Research Center,  Principal Research Scientist, Korea Institute of Science and Technology-Gangneung Institute, Korea

9:30-9:50

Title: The Banerji Protocols: Disease-Specific Ultra-dilute Medicines for the Treatment of Brain Tumors
Dr. Pratip Banerji, Deputy Director, PBH Research Foundation, India

9:50-10:10

Title: A Evidence Based Cases of Terminal Malignances Treated with Botanical Medicine,  A Novel Multi Molicules Approach in Cancer Therapeutics
Dr. Ranjitsinh Solanki, Solankiz Herbal Healthcare, India

10:10-10:25

Coffee Break

10:25-10:45

Title: The Banerji Protocols: Disease-specific Ultra-dilute Medicines for the Treatment of Lung Cancer
Dr. Prasanta Banerji, Founder & Managing Trustee, PBH Research Foundation (PBHRF), India

Track 8-3: Nutritional Oncology and Food-borne Carcinogens

Time: 10:45-11:50, June 23,2010 (Wednesday)     Place: Conference Hall E, 2F

Session Chair

Dr. Alastair Sammon, Consultant, Gloucestershire Royal Hospital; Lecturer, University of Bristol; Visiting Fellow, Cranfield University, UK

10:45-11:05

Title: The Value of Immunonutrition in Gastrointestinal Cancer Patients
Dr. Stanislaw Klek, Department of Surgery, Jagiellonian University Medical College, Poland

11:05-11:25

Title: Maize and Squamous Cancer of the Oesophagus in Africa
Dr. Alastair Sammon, Consultant, Gloucestershire Royal Hospital, UK

11:25-11:50

Title: Seasonal Vitamin D and Implications for Cancer Prevention
Dr. Michael Kimlin, Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia

Track 8-4: Cancer Rehabilitation, Nutrition and Complementary Therapy

Time: 15:45-17:05, June 23,2010 (Wednesday)    Place: Conference Hall G, 1F

Session Chair

Dr. Alexandra McManus, Associate Professor, Director, Centre of Excellence for Science, Seafood & Health (CESSH), Curtin Health Innovation Research Institute (CHIRI) | Faculty of Health Sciences, Curtin University, Australia

15:45-16:05

Title: Stress Related Cancer Manifestation in Dogs and Cats
Dr. Paul McCutcheon, Founder and Director, East York Animal Clinic Holistic Centre, Canada

16:05-16:25

Title: New Concepts of Selenium in Prostate Cancer Intervention
Dr. Haitao Zhang, Assistant Professor in the Department of Pathology and Laboratory Medicine at Tulane University School of Medicine, USA

16:25-16:45

Title: Metabolic Stem Cell (MSC) based Lifestyle Intervention against Lifestyle- related Cancer
Dr. Kazuhisa Maeda, Associate Professor, Department of Complementary & Alternative Medicine, Osaka University Graduate School of Medicine, Japan

16:45-17:05

Title: Using Nutritional Modelling to Develop Cancer Prevention Diets for High Risk Groups
Dr. Alexandra McManus, Associate Professor, Director, Centre of Excellence for Science, Seafood & Health (CESSH), Curtin Health Innovation Research Institute (CHIRI) | Faculty of Health Sciences, Curtin University, Australia